WO2021100676A1 - External preparation for skin - Google Patents

External preparation for skin Download PDF

Info

Publication number
WO2021100676A1
WO2021100676A1 PCT/JP2020/042695 JP2020042695W WO2021100676A1 WO 2021100676 A1 WO2021100676 A1 WO 2021100676A1 JP 2020042695 W JP2020042695 W JP 2020042695W WO 2021100676 A1 WO2021100676 A1 WO 2021100676A1
Authority
WO
WIPO (PCT)
Prior art keywords
mass
less
skin
component
external preparation
Prior art date
Application number
PCT/JP2020/042695
Other languages
French (fr)
Japanese (ja)
Inventor
典子 手島
真由美 武谷
Original Assignee
花王株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 花王株式会社 filed Critical 花王株式会社
Priority to CN202080079384.4A priority Critical patent/CN114727920A/en
Priority to KR1020227015676A priority patent/KR20220080162A/en
Publication of WO2021100676A1 publication Critical patent/WO2021100676A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0254Platelets; Flakes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00Compounds of titanium
    • C01G23/04Oxides; Hydroxides
    • C01G23/047Titanium dioxide

Definitions

  • the present invention relates to an external preparation for skin.
  • Patent Document 1 International Publication No. 2009/017104 states that infrared rays prevent infrared rays from reaching deeper into the dermis and subcutaneous tissues than the tissues of the skin, and those by infrared rays.
  • Patent Document 2 Japanese Unexamined Patent Publication No. 2017-95361 discloses a near-infrared protective cosmetic composition composed of titanium oxide powder and zinc oxide powder, which has both excellent near-infrared protection effect and high transparency. Has been done.
  • the present invention relates to the following [1] and [2].
  • the compounding amount of the component (a) is 5% by mass or more and 70% by mass or less, and the compounding amount of the component (b) is 100% by mass with respect to the total compounding amount of the components (a) to (c) of 100% by mass.
  • An external preparation for skin having an amount of 15% by mass or more and 75% by mass or less and a blending amount of the component (c) of 5% by mass or more and 70% by mass or less.
  • component (a), component (b) and component (c) in 100 mass% of the total compounding amount of component (a)-(c) in the external preparation for skin.
  • the external preparation for skin of the present invention contains the following components (a) to (c): (A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less, (B) Plate-shaped metal oxides with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped metal oxides with a thickness of 180 nm or more and 200 nm or less.
  • the compounding amount of the component (a) is 5% by mass or more and 70% by mass or less, and the compounding amount of the component (b) is 100% by mass with respect to the total compounding amount of the components (a) to (c) of 100% by mass.
  • the external preparation for skin of the present invention has the above structure, it has an excellent infrared ray protection effect and can obtain a natural color that blends with the skin color when applied to the skin.
  • an external preparation for skin with further improved infrared protection function is desired rather than the disclosed techniques of Patent Documents 1 and 2.
  • the external preparations for skin as a skin cosmetic, if it exhibits redness or bluish color, it becomes an unnatural color when applied to the skin, so that it is also required to have a color that matches the color of the skin.
  • the present invention relates to an external preparation for skin that has an excellent infrared protection effect, is less likely to have redness or bluish color when applied to the skin, and can obtain a natural color that blends in with the skin color.
  • the present inventors have found that a skin external preparation containing a combination of plate-like metal oxides having a predetermined thickness range and different thicknesses in a predetermined ratio can solve the above-mentioned problems.
  • the external preparation for skin of the present invention has an excellent infrared protective effect, and when applied to the skin, redness and blueness are less likely to be recognized, and a natural color that blends in with the skin color can be obtained.
  • skin makeup It is useful as a fee.
  • the thickness of the plate-shaped metal oxide means the length of the shortest shaft of the plate-shaped metal oxide particles.
  • infrared rays mean electromagnetic waves having a wavelength of 780 nm to 1 mm.
  • the external preparation for skin of the present invention is particularly excellent in the near-infrared ray protection effect having a wavelength of 780 nm to 2500 nm.
  • the infrared protection rate with a wavelength of 1500 nm is used as an index as the infrared protection effect.
  • the dosage form of the external preparation for skin of the present invention is not particularly limited, but it is preferably liquid, gel-like, or cream-like from the viewpoint of ease of application to the skin.
  • the external preparation for skin may be in the form of an emulsified composition, and the emulsified composition may be either an oil-in-water emulsified composition or a water-in-oil emulsified composition.
  • the external skin preparation of the present invention is preferably a skin cosmetic such as a sunscreen cosmetic (skin water, cream, milky lotion, beauty essence, etc.), suntan, makeup base cosmetic, and the like.
  • the external preparation for skin of the present invention contains the following components (a) to (c): (A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less, (B) A plate-shaped metal oxide having a thickness of 125 nm or more and 145 nm or less, and (c) a plate-shaped metal oxide having a thickness of 180 nm or more and 200 nm or less are blended.
  • the external preparation for skin of the present invention has an excellent infrared protection effect, a high heat-shielding feeling can be obtained, and the skin becomes white. It is difficult to use, and when applied to the skin, it also has the effect of obtaining a natural color that blends in with the skin color. The reason for this is not clear, but it can be considered as follows.
  • the present inventors selectively increase the reflectance of light in the infrared region by the interference effect of light by using a plate-shaped metal oxide having a predetermined thickness as an infrared protective agent in an external preparation for skin.
  • a plate-shaped metal oxide having a predetermined thickness as an infrared protective agent in an external preparation for skin.
  • an external preparation for skin containing a plate-like metal oxide as an infrared protective agent may have an unnatural color that does not blend with the skin, such as redness and blueness being observed when applied to the skin. It was found that there is.
  • the present inventors have achieved a high infrared protection effect by blending the components (a) to (c), which are plate-shaped metal oxides having different thicknesses, in the predetermined ratios.
  • the components (a) to (c) exhibit red, blue, and green interference colors, respectively, due to the wavelength of the reflected light.
  • the skin It is probable that a natural shade that blends in with the skin color could be obtained when applied to.
  • the thickness of the components (a) to (c) from the viewpoint of obtaining an excellent infrared protection effect by the above-mentioned action mechanism, and from the viewpoint of obtaining a natural color without becoming white when the external preparation for skin is applied to the skin. Is preferably in the following range, respectively.
  • the thickness of the component (a) is 100 nm or more, preferably 105 nm or more, 120 nm or less, preferably 115 nm or less.
  • the component (a) having a thickness in the above range exhibits a reddish interference color due to the wavelength of the reflected light.
  • the thickness of the component (b) is 125 nm or more, preferably 130 nm or more, and 145 nm or less, preferably 140 nm or less.
  • the component (b) having a thickness in the above range exhibits a bluish interference color due to the wavelength of the reflected light.
  • the thickness of the component (c) is 180 nm or more, preferably 185 nm or more, and 200 nm or less, preferably 195 nm or less.
  • the component (c) having a thickness in the above range exhibits a greenish interference color due to the wavelength of the reflected light.
  • the thicknesses of the components (a) to (c) can all be determined from the observation image by the scanning electron microscope (SEM).
  • the plate-shaped metal oxides of the components (a) to (c) are observed by SEM under the condition of an observation magnification of 10,000 times, and the thickness of 50 particles in the observation image is measured. Therefore, it is obtained by calculating the average value of the thickness per number.
  • the thicknesses of the components (a) to (c) can be measured by the method described in Examples.
  • the average particle size of the components (a) to (c) is preferably 20 ⁇ m or less, more preferably 15 ⁇ m or less, still more preferably 12 ⁇ m or less, and further. It is preferably 10 ⁇ m or less.
  • the average particle size of the components (a) to (c) is determined from the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of obtaining a natural color tone without becoming white when an external preparation for skin is applied to the skin. It is preferably 1 ⁇ m or more, more preferably 2 ⁇ m or more, still more preferably 3 ⁇ m or more, still more preferably 5 ⁇ m or more.
  • the specific range of the average particle size of the components (a) to (c) is preferably 1 ⁇ m or more and 20 ⁇ m or less, more preferably 2 ⁇ m or more and 15 ⁇ m or less, still more preferably 2 ⁇ m or more and 12 ⁇ m or less, still more preferably 3 ⁇ m or more and 10 ⁇ m or less. Even more preferably, it is 5 ⁇ m or more and 10 ⁇ m or less.
  • the average particle size of the components (a) to (c) is a median diameter (D50) measured at a particle size reference volume using a laser diffraction / scattering type particle size distribution measuring device. It can be measured by the method described.
  • the aspect ratios of the components (a) to (c) are preferably 10 or more. It is preferably 20 or more, more preferably 30 or more, and even more preferably 35 or more. Further, from the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of preventing whitening and reducing glare when the external preparation for skin is applied to the skin, it is preferably 200 or less, more preferably 150 or less, still more preferably. It is 100 or less, more preferably 90 or less.
  • the specific range of the aspect ratios of the components (a) to (c) is preferably 10 or more and 200 or less, more preferably 10 or more and 150 or less, still more preferably 10 or more and 100 or less, still more preferably 20 or more and 100 or less, and more. It is more preferably 30 or more and 100 or less, and even more preferably 35 or more and 90 or less.
  • the aspect ratios of the components (a) to (c) can be calculated from (average particle size / thickness).
  • the degree of glare when the external preparation for skin is applied to the skin is evaluated by measuring the gloss value at an angle of 60 ° using a gloss value measuring device for the coating film obtained by applying the external preparation for skin. Can be done.
  • metal oxides constituting the components (a) to (c) a material having a high refractive index can obtain a higher optical interference effect.
  • preferable metal oxides constituting the components (a) to (c) include titanium oxide, zinc oxide, zirconium oxide, iron oxide, aluminum oxide, cerium oxide and the like. Among these, one or more selected from the group consisting of titanium oxide and zinc oxide is preferable, and titanium oxide is more preferable. That is, the components (a) to (c) are preferably one or more selected from the group consisting of plate-shaped titanium oxide and plate-shaped zinc oxide, and more preferably plate-shaped titanium oxide.
  • the crystal structure of titanium oxide may be rutile type, anatase type, or amorphous, but the rutile type is preferable from the viewpoint of obtaining an excellent infrared protection effect and a feeling of heat shielding.
  • the plate-shaped metal oxides of the components (a) to (c) may not be surface-treated, and may be treated with a hydrophobic treatment by a known method, if necessary, in order to enhance the dispersibility in the external preparation for skin. It may be the one which has been subjected to the surface treatment of.
  • the plate-shaped metal oxides of the components (a) to (c) are distinguished from those in which the surface of particles other than the metal oxide is surface-treated with the metal oxide.
  • Examples of the surface treatment agent used for the surface treatment of the plate-shaped metal oxides according to the components (a) to (c) include silicone; alkylalkoxysilane; fluorine-containing compounds such as perfluoroalkyl phosphate and perfluoroalcohol; N. -Amino acids such as acylglutamic acid; other examples include lecithin; metal soap; fatty acids such as stearic acid; alkyl phosphates and the like.
  • one or more selected from the group consisting of silicone and alkylalkoxysilane is preferable from the viewpoint of enhancing the dispersibility of the components (a) to (c) in the external preparation.
  • Silicone as a surface treatment agent is not particularly limited, and for example, methylpolysiloxane, dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, methylcyclopolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, etc.
  • Siloxane oil can be mentioned.
  • the alkylalkoxysilane as the surface treatment agent those having a branched or linear alkyl group having 6 to 20 carbon atoms are preferable, and examples thereof include octyltriethoxysilane and octyltrimethoxysilane.
  • the surface treatment agent is selected from the group consisting of methylpolysiloxane, dimethylpolysiloxane, methylhydrogenpolysiloxane, (alkyl acrylate / dimethicone) copolymer, and octylriethoxysilane1. More than a seed is preferred.
  • the blending amount of the component (a) is 5% by mass or more and 70% by mass or less with respect to 100% by mass of the total blending amount of the components (a) to (c), and the blending amount of the component (b). Is 15% by mass or more and 75% by mass or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less.
  • the blending amount of each component with respect to the total blending amount of the components (a) to (c) is within the above range, an excellent infrared ray protection effect and a natural color when the external preparation for skin is applied to the skin can be obtained. It is compatible.
  • the skin external preparation of the present invention has a total blending amount of 100% by mass of the components (a) to (c) from the viewpoint of achieving both an excellent infrared protection effect and a natural color when the skin external preparation is applied to the skin. It is preferable that the blending ratio of the component (a), the component (b) and the component (c) with respect to the above condition 1 satisfies the following condition 1, and more preferably the following condition 2 is satisfied.
  • Condition 1 In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
  • (A, b, c) (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12), (57 , 33, 10)
  • Condition 2 In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
  • (A, b, c) (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22), (42) , 43, 15)
  • FIG. 1 is a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) in the total blending amount of the components (a) to (c) in the external preparation for skin of 100% by mass. ..
  • the blending amount of the component (a) in the region 1 surrounded by the thick solid line, is 5% by mass or more and 70% by mass or less with respect to the total blending amount of 100% by mass of the components (a) to (c).
  • the composition region in which the blending amount of the component (b) is 15% by mass or more and 75% by mass or less and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less is shown.
  • the region 2 surrounded by the broken line in the three-phase diagram of FIG. 1 is a composition region satisfying the above condition 1.
  • (a, b, c) (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12). ) And (57, 33, 10) are indicated by " ⁇ ".
  • the region 3 surrounded by the alternate long and short dash line in the three-phase diagram of FIG. 1 is a composition region that satisfies the above condition 2.
  • (a, b, c) (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22). ) And (42, 43, 15) are indicated by “ ⁇ ”.
  • the total amount of the components (a) to (c) in the external preparation for skin of the present invention is preferably 1% by mass or more, more preferably 1.5% by mass or more, still more preferably, from the viewpoint of obtaining an excellent infrared protection effect. Is 2% by mass or more. Further, from the viewpoint of obtaining a natural color that does not easily turn white when the external preparation for skin is applied to the skin and from the viewpoint of economy, it is preferably 35% by mass or less, more preferably 25% by mass or less, still more preferably 20. It is mass% or less, more preferably 15 mass% or less, still more preferably 10 mass% or less.
  • the specific range of the total blending amount of the components (a) to (c) in the external preparation for skin of the present invention is preferably 1% by mass or more and 35% by mass or less, more preferably 1% by mass or more and 25% by mass or less, still more preferably. Is 1% by mass or more and 20% by mass or less, more preferably 1% by mass or more and 15% by mass or less, further preferably 1.5% by mass or more and 10% by mass or less, still more preferably 2% by mass or more and 10% by mass or less. Is.
  • the external preparation for skin of the present invention does not exclude the addition of plate-shaped metal oxides other than the components (a) to (c), but the amount thereof is small from the viewpoint of obtaining the effects of the present invention. Is preferable.
  • the ratio of the components (a) to (c) in the total amount of the plate-shaped metal oxide blended in the external preparation for skin is preferably 70% by mass or more, more preferably 80% by mass or more, still more preferably. Is 90% by mass or more, more preferably 95% by mass or more, and 100% by mass or less.
  • plate-shaped metal oxides can also be used as the components (a) to (c).
  • CQV's "Featheleve PT-9001K", “Featheleve PT-7001K”, “Featheleve PT-7401K”, “Featheleve PT-7801K”, “Featheleve PT-7901K” and the like can be mentioned. .. It is more preferable to use these plate-shaped titanium oxides that have undergone the surface treatment as the components (a) to (c).
  • the pulverization treatment method is not particularly limited, and a known method can be used.
  • the pulverization treatment may be performed at any stage before the surface treatment and after the surface treatment.
  • the external preparation for skin of the present invention further contains a feel-improving agent as a component (d) from the viewpoint of suppressing stickiness when applied to the skin and obtaining a smooth and good feel when an oil agent or the like described later is blended. It is preferable to do so.
  • the feel improving agent may be any of organic particles, inorganic particles other than the above-mentioned components (a) to (c), and a mixture thereof, and those usually blended in cosmetics can be used. From the viewpoint of obtaining a good feel when applied to the skin, the shape of the particles is preferably spherical. Further, those having irregularities on the particle surface or those having a porous surface may be used.
  • organic particles used as the component (d) include acrylic resin, silicone resin, polystyrene resin, polyamide resin, polyester resin, polyolefin resin, polystyrene resin, polyurethane resin, vinyl resin, urea resin, phenol resin, and fluororesin.
  • resin particles composed of resins such as melamine resin, epoxy resin, polycarbonate resin, acrylic-silicone copolymer resin, acrylic-styrene copolymer resin, and cellulose. These resin particles may be crosslinked resin particles or non-crosslinked resin particles.
  • Metal oxide particles are preferable as the inorganic particles other than the components (a) to (c), and examples of the metal oxide include titanium oxide, zinc oxide, zirconium oxide, iron oxide, aluminum oxide, and cerium oxide. Be done. Among these, one or more selected from the group consisting of titanium oxide and zinc oxide is preferable, and titanium oxide is more preferable.
  • the component (d) is preferably a spherical inorganic particle, more preferably a spherical metal oxide particle, and further preferably one selected from the group consisting of spherical titanium oxide particles and spherical zinc oxide particles. These are the above, and even more preferably, spherical titanium oxide particles.
  • the average particle size of the particles used as the component (d) is preferably 0.1 ⁇ m or more, more preferably 0.2 ⁇ m or more, still more preferably 0.2 ⁇ m or more, from the viewpoint of suppressing stickiness when applied to the skin and obtaining a good feel. Is 0.5 ⁇ m or more. Further, from the viewpoint of suppressing stickiness when applied to the skin to obtain a good feel, and from the viewpoint of preventing whitening when the external preparation for skin is applied to the skin, it is preferably 10 ⁇ m or less, more preferably 5 ⁇ m or less, and further. It is preferably 2 ⁇ m or less.
  • the specific range of the average particle size of the particles used as the component (d) is preferably 0.1 ⁇ m or more and 10 ⁇ m or less, more preferably 0.2 ⁇ m or more and 5 ⁇ m or less, and further preferably 0.5 ⁇ m or more and 2 ⁇ m or less.
  • the average particle size can be measured by the same method as described above.
  • the component (d) When the component (d) is used in the external preparation for skin of the present invention, its content is preferably 1% by mass or more in the external preparation for skin from the viewpoint of suppressing stickiness when applied to the skin and obtaining a good feel. , More preferably 1.5% by mass or more, still more preferably 2% by mass or more. Further, from the viewpoint of suppressing stickiness when applied to the skin to obtain a good feel, and from the viewpoint of preventing whitening when the external preparation for skin is applied to the skin, it is preferably 20% by mass or less, more preferably 15% by mass. % Or less, more preferably 10% by mass or less.
  • the specific range of the content of the component (d) in the external preparation for skin of the present invention is preferably 1% by mass or more and 20% by mass or less, more preferably 1% by mass or more and 15% by mass or less, and further preferably 1% by mass or more. It is 10% by mass or less, more preferably 1.5% by mass or more and 10% by mass or less, and even more preferably 2% by mass or more and 10% by mass or less.
  • the mass ratio [ ⁇ (a) + (b) + (c) ⁇ / (d)] of the total amount of the components (a) to (c) and the component (d) is determined.
  • it is preferably 0.1 or more, more preferably 0.2 or more, and further. It is preferably 0.5 or more.
  • it is preferably 5 or less, more preferably 3 or less, still more preferably 2 or less, still more preferably 1.5 or less.
  • the specific range of the mass ratio [ ⁇ (a) + (b) + (c) ⁇ / (d)] is preferably 0.1 or more and 5 or less, more preferably 0.2 or more and 3 or less, and further preferably 0. It is .5 or more and 2 or less, more preferably 0.5 or more and 1.5 or less.
  • the external preparation for skin of the present invention preferably further contains an ultraviolet absorber as a component (e) from the viewpoint of imparting an ultraviolet protection effect in addition to the infrared protection effect.
  • an organic ultraviolet absorber is preferable, and an oil-soluble organic ultraviolet absorber or a water-soluble organic ultraviolet absorber can be used.
  • the component (e) is preferably an oil-soluble organic UV absorber from the viewpoints of UV protection effect, natural appearance when applied to the skin, good cosmetic adhesion after application, and suppression of stickiness. ..
  • oil-soluble means that it is water-insoluble, and specifically means that the solubility in water is 1 w / w% or less.
  • the component (e) is distinguished from an inorganic ultraviolet absorber such as an ultraviolet absorber in which the surface of an inorganic filler is coated with an ultraviolet absorbing material.
  • an oil-soluble one among salicylic acid-based UV absorbers, cinnamic acid-based UV absorbers, benzoylmethane-based UV absorbers, and other organic UV absorbers can be used.
  • salicylic acid-based UV absorbers such as homomentyl salicylate and octyl salicylate; 2-Ethylhexyl paramethoxycinnamate (for example, "Ubinal MC80" manufactured by BASF), glyceryl diparamethoxycinnamate mono-2-ethylhexanate, methyl 2,5-diisopropylsilicate, methylbis trimethoxycinnamate (Trimethylsiloxy) Cinnamic acid-based ultraviolet absorbers such as silylisopentyl and isopropyl-diisopropylsilicate ester mixture of paramethoxycinnamate; Benzoylmethane-based UV absorbers such as 4-is
  • salicylic acid-based UV absorber As a water-soluble organic UV absorber, salicylic acid-based UV absorber, silicic acid-based UV absorber, benzoylmethane-based UV absorber, and other organic UV absorbers have a solubility in water of 1 w / w%. Those exceeding the above can be used, and examples thereof include salicylic acid triethanolamine salt, p-methoxyhydrosilicate diethanolamine salt and the like.
  • the component (e) includes 2-ethylhexyl paramethoxysilicate, 4-tert-butyl-4'-methoxydibenzoylmethane, octocrylene, and dimethoxybenzylidene dioxoimidazolidine propionic acid.
  • 2-Ethylhexyl, diethylaminohydroxybenzoyl hexyl benzoate, bisethylhexyloxyphenol methoxyphenyltriazine, methylenebisbenzotriazolyltetramethylbutylphenol, and 2,4,6-tris [4- (2-ethylhexyloxycarbonyl) anilino ] -1,3,5-Triazine is preferably one or more selected from the group consisting of 2-ethylhexyl paramethoxysilicate, hexyl diethylaminohydroxybenzoylbenzoate, bisethylhexyloxyphenol methoxyphenyltriazine, and 2,4.
  • one or more selected from the group consisting of 6-tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine More preferably, it is one or more selected from the group consisting of 2-ethylhexyl paramethoxycinnamate, hexyl diethylaminohydroxybenzoylbenzoate, and bisethylhexyloxyphenol methoxyphenyl triazine.
  • the content thereof is preferably 0.2% by mass or more, more preferably 1% by mass in the external preparation for skin from the viewpoint of imparting an excellent ultraviolet protection effect. % Or more, more preferably 3% by mass or more, still more preferably 5% by mass or more. Further, from the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of obtaining a natural color tone that is less likely to turn white when an external preparation for skin is applied to the skin, it is preferably 30% by mass or less, more preferably 25% by mass or less. , More preferably 20% by mass or less, and even more preferably 15% by mass or less.
  • the specific range of the content of the component (e) in the external preparation for skin is preferably 0.2% by mass or more and 30% by mass or less, more preferably 1% by mass or more and 25% by mass or less, and further preferably 3% by mass or more. It is 20% by mass or less, more preferably 5% by mass or more and 15% by mass or less.
  • the mass ratio [ ⁇ (a) + (b) + (c) ⁇ / (e)] of the total amount of the components (a) to (c) and the component (e) is determined.
  • it is preferably 0.1 or more, more preferably 0.2 or more, and further. It is preferably 0.3 or more.
  • it is preferably 5 or less, more preferably 3 or less, still more preferably 1 or less, still more preferably 0.5 or less.
  • the specific range of the mass ratio [ ⁇ (a) + (b) + (c) ⁇ / (e)] is preferably 0.1 or more and 5 or less, more preferably 0.1 or more and 3 or less, and further preferably 0. .2 or more and 1 or less, more preferably 0.3 or more and 1 or less, still more preferably 0.3 or more and 0.5 or less.
  • the external preparation for skin of the present invention has a viewpoint of improving the applicability to the skin by dispersing the components (a) to (c) and dispersing or dissolving other compounding components, as well as the oil-in-water type or water in oil. From the viewpoint of preparing a type of external preparation for skin, it is preferable to further contain an oil agent as the component (f).
  • an oil agent either a non-volatile oil (f1) or a volatile oil (f2) other than the component (e) can be used, and these can also be used in combination.
  • the oil agent (f) preferably contains at least a non-volatile oil (f1) from the viewpoint of dissolving the oil-soluble ultraviolet absorber.
  • Non-volatile oil (f1) The external preparation for skin of the present invention preferably contains a non-volatile oil (f1) as the oil (f).
  • the non-volatile oil means an oil having an evaporation amount of less than 20% at 25 ° C. for 6 hours, which is measured by the following method (1).
  • Method (1) A filter paper having a diameter of 90 mm is placed in a glass petri dish having a diameter of 120 mm, 1 g of a sample is placed on the filter paper, and the sample is stored in a room (25 ° C.) at 65% RH. Then, the residue of the sample after 6 hours is measured, and the amount of evaporation is calculated.
  • the component (f1) is preferably liquid at 25 ° C. under 1 atm. More specifically, the component (f1) has a viscosity at 25 ° C. of preferably 500 mPa ⁇ s or less, more preferably 300 mPa ⁇ s or less, still more preferably 100 mPa ⁇ s or less, and even more preferably. It is 50 mPa ⁇ s or less, preferably 5 mPa ⁇ s or more.
  • the viscosity was determined by using a B-type viscometer "TVB-10" (manufactured by Toki Sangyo Co., Ltd.). It can be measured under the conditions of 1, 25 ° C., 60 rpm and 1 minute.
  • component (f1) examples include non-volatile oils other than the component (e) that are liquid at 25 ° C., ester oils, silicone oils, hydrocarbon oils, higher fatty acids, and higher alcohols.
  • non-volatile liquid ester oil examples include isononyl isononanoate, isotridecyl isononanoate, isopropyl myristate, isocetyl myristate, octyldodecyl myristate, isopropyl palmitate, ethylhexyl palmitate, 2-hexyldecyl palmitate, and tri2.
  • pentylglycol and alkyl benzoate such as alkyl benzoate (C12 to C15) can be mentioned.
  • a monoester of a fatty acid having 12 or more and 18 or less carbon atoms and a branched alcohol having 2 or more and 22 or less carbon atoms, and 6 carbon atoms from the viewpoint of obtaining a natural color when applied to the skin and suppressing stickiness, a monoester of a fatty acid having 12 or more and 18 or less carbon atoms and a branched alcohol having 2 or more and 22 or less carbon atoms, and 6 carbon atoms.
  • Diesters with the following branched dialcohols, alkyl benzoates (C12 to C15) (for example, Finsolve TN; manufactured by Innospec Active Chemicals LLC) and the like are preferable, and specifically, isopropyl myristate, isosetyl myristate, octyldodecyl myristate, etc.
  • One or more selected from the group consisting of neopentyl glycol dicaprate and alkyl benzoate (C12 to C15) is more preferable, and one or more selected from the group consisting of isopropyl palmitate and alkyl benzoate (C12 to C15) is more preferable. More preferred.
  • methylpolysiloxane is preferable from the viewpoint of suppressing stickiness when applied to the skin, and methylpolysiloxane having a viscosity at 25 ° C. of 20 mPa ⁇ s or less is more preferable.
  • non-volatile liquid hydrocarbon oils examples include liquid paraffin, light liquid isoparaffin such as hydrogenated polyisobutene, heavy liquid isoparaffin, liquid zokerite, squalane, pristane, squalene, and isohexadecane.
  • light liquid isoparaffin such as hydrogenated polyisobutene
  • heavy liquid isoparaffin such as hydrogenated polyisobutene
  • liquid zokerite such as hydrogenated polyisobutene
  • squalane such as a heavy liquid isoparaffin
  • pristane such as pristane
  • squalene such as pristane
  • isohexadecane examples include liquid paraffin, light liquid isoparaffin such as hydrogenated polyisobutene, heavy liquid isoparaffin, liquid zokerite, squalane, pristane, squalene, and isohexadecane.
  • non-volatile liquid higher fatty acid examples include fatty acids having 12 or more and 22 or less carbon atoms, and specific examples thereof include oleic acid, isostearic acid, linoleic acid, and linoleic acid.
  • non-volatile liquid higher alcohol examples include alcohols having 12 to 28 carbon atoms, and specific examples thereof include oleyl alcohol, 2-decyltetradecinol, dodecanol, isostearyl alcohol, and octyldodecanol. Can be mentioned.
  • the component (f1) is one or more selected from the group consisting of ester oils, silicone oils and hydrocarbon oils, preferably from the viewpoint of suppressing stickiness when applied to the skin, among non-volatile oils that are liquid at 25 ° C. It is more preferably one or more selected from the group consisting of ester oils and hydrocarbon oils, and even more preferably selected from the group consisting of alkyl benzoate (C12-15), isopropyl palmitate, and light liquid isoparaffin. It is one or more kinds.
  • the external preparation for skin of the present invention contains the component (f1), the content thereof disperses the components (a) to (c) and disperses or dissolves other compounding components to improve the applicability to the skin.
  • the content thereof disperses the components (a) to (c) and disperses or dissolves other compounding components to improve the applicability to the skin.
  • it is preferably 1% by mass or more, more preferably 4% by mass or more, and further preferably 8% by mass or more.
  • it is preferably 99% by mass or less, more preferably 90% by mass or less, still more preferably 80% by mass or less, still more preferably.
  • the specific range of the content of the component (f1) in the external preparation for skin is preferably 1% by mass or more and 99% by mass or less, more preferably 4% by mass or more and 90% by mass or less, and further preferably 8% by mass or more and 80% by mass. % Or less, more preferably 8% by mass or more and 50% by mass or less, still more preferably 8% by mass or more and 30% by mass or less.
  • the mass ratio of the total amount of the components (a) to (c) to the component (f1) [ ⁇ (a) + (b) + (c) ⁇ / (F1)] is preferably 0.01 or more, from the viewpoint of obtaining an excellent ultraviolet protection effect, and from the viewpoint of obtaining a natural color tone without becoming white when an external preparation for skin is applied to the skin. It is preferably 0.05 or more, more preferably 0.1 or more, and prepares an oil-in-water type or a water-in-oil type skin external preparation from the viewpoint of dissolving an oil-soluble ultraviolet absorber, improving coatability, and preparing.
  • the specific range of the mass ratio [ ⁇ (a) + (b) + (c) ⁇ / (f1)] is preferably 0.01 or more and 10 or less, more preferably 0.01 or more and 5 or less, and further preferably 0. It is 0.05 or more and 3 or less, more preferably 0.1 or more and 1 or less, and even more preferably 0.3 or more and 0.5 or less.
  • the mass ratio [(e) / (f1)] is preferably 0.01 from the viewpoint of obtaining an excellent ultraviolet protection effect.
  • the above is more preferably 0.02 or more, further preferably 0.05 or more, still more preferably 0.1 or more, and when an oil-soluble ultraviolet absorber is used as the component (e), its dissolution. From the viewpoint of sex, it is preferably 10 or less, more preferably 5 or less, still more preferably 3 or less.
  • the specific range of the mass ratio [(e) / (f1)] is preferably 0.01 or more and 10 or less, more preferably 0.02 or more and 5 or less, still more preferably 0.05 or more and 3 or less, still more preferably. It is 0.1 or more and 3 or less.
  • the volatile oil is an oil agent other than the above-mentioned ultraviolet absorber (e), and the amount of evaporation at 25 ° C. for 6 hours measured by the following method (1) is 20% or more.
  • Method (1) A filter paper having a diameter of 90 mm is placed in a glass petri dish having a diameter of 120 mm, 1 g of a sample is placed on the filter paper, and the sample is stored in a room (25 ° C.) at 65% RH. Then, the residue of the sample after 6 hours is measured, and the amount of evaporation is calculated.
  • the component (f2) is preferably a volatile silicone oil, and more preferably a linear organopolysiloxane or a cyclic organopolysiloxane that is liquid and volatile at 25 ° C.
  • linear organopolysiloxane include octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, 1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl) oxy. ] -Trisiloxane can be mentioned.
  • cyclic organopolysiloxane examples include 4- to 6-membered cyclic siloxanes having an alkyl group having 1 or more and 5 or less carbon atoms as a substituent, and specific examples thereof include octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane. Can be mentioned.
  • cyclic organopolysiloxane is preferable, and decamethylcyclopentasiloxane is more preferable, from the viewpoint of suppressing stickiness when applied to the skin.
  • volatile silicone oils that can be used as component (f2) include “KF-96A-1cs” (octamethyltrisiloxane) and “KF-96L-1.5cs” manufactured by Shin-Etsu Chemical Industry Co., Ltd.
  • the content thereof can be appropriately selected depending on the dosage form of the external preparation for skin, but is preferably 1% by mass or more, more preferably 5% by mass or more. , More preferably, it can be 10% by mass or more. Further, from the viewpoint of suppressing stickiness when applied to the skin, it can be preferably 85% by mass or less, more preferably 80% by mass or less, and further preferably 75% by mass or less.
  • the specific range of the content of the component (f2) in the external preparation for skin is preferably 1% by mass or more and 85% by mass or less, more preferably 5% by mass or more and 80% by mass or less, and further preferably 10% by mass or more and 75% by mass. % Or less.
  • the external preparation for skin of the present invention is necessary from the viewpoint of dispersing or dissolving the components (a) to (c) and other compounding components, and from the viewpoint of preparing an oil-in-water type or a water-in-oil type skin external preparation.
  • an aqueous medium can be further contained.
  • the aqueous medium is not particularly limited as long as it can disperse or dissolve the components (a) to (c) and other compounding components, and is, for example, water; ethanol, isopropyl alcohol, butyl alcohol and the like having 4 carbon atoms.
  • the following monohydric alcohols low molecular weight diols having 6 or less carbon atoms such as 1,3-butylene glycol, glycerin, ethylene glycol, propylene glycol, diethylene glycol, and dipropylene glycol, and triol can be mentioned.
  • monohydric alcohols low molecular weight diols having 6 or less carbon atoms
  • one or more selected from the group consisting of water and a monohydric alcohol having 4 or less carbon atoms is preferable, and one or more selected from the group consisting of water and ethanol is more preferable.
  • the content thereof can be appropriately selected depending on the dosage form of the external preparation for skin, but is preferably 5% by mass or more, more preferably 8% by mass or more, still more preferably. It can be 10% by mass or more. Further, it can be preferably 99% by mass or less, more preferably 90% by mass or less, still more preferably 70% by mass or less, still more preferably 50% by mass or less.
  • the external preparation for skin of the present invention contains other components as required, such as surfactants, ultraviolet scattering agents, antiperspirants, fragrances, moisturizers, thickeners, bactericides, and pH adjusters. , Antioxidants, preservatives and the like can also be contained.
  • the method for producing the external preparation for skin of the present invention is not particularly limited, and a known method can be appropriately used depending on the dosage form of the external preparation for skin.
  • a method of blending the components (a) to (c) and all other components and uniformly mixing them with a homogenizer, a disper, or the like can be mentioned.
  • blending an aqueous medium it is also possible to use a method in which all the components other than the aqueous medium are blended, uniformly mixed with a disper or the like, then the aqueous medium is blended and further stirred and mixed with a homogenizer or the like.
  • the present invention also provides a method for protecting against infrared rays of the skin by applying the external preparation for skin of the present invention to the skin.
  • the protective method of the present invention is not particularly limited as long as it has a step of applying the external preparation for skin of the present invention to the skin.
  • the infrared protection rate at a wavelength of 1500 nm is preferably 10% or more, more preferably 12% or more, still more preferably 15% or more.
  • the infrared protection rate (%) is a value represented by 100-X (%) when the infrared transmittance measured by a spectrophotometer is X (%), and specifically, the method described in Examples. Can be measured by.
  • the present invention further discloses the following embodiments.
  • the blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass with respect to the total blending amount of the components (a) to (c) of 100% by mass. % Or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less, which is an external preparation for skin.
  • the plate-like metal oxide is preferably one or more selected from the group consisting of silicone and alkylalkoxysilane, more preferably methylpolysiloxane, dimethylpolysiloxane, methylhydrogenpolysiloxane, (alkyl acrylate / dimethicone) copolymer.
  • the thickness of the component (a) is preferably 105 nm or more and 115 nm or less, the thickness of the component (b) is preferably 130 nm or more and 140 nm or less, and the thickness of the component (c) is preferably 185 nm.
  • the external preparation for skin according to any one of ⁇ 1> to ⁇ 3>, which is 195 nm or less.
  • the average particle size of the components (a) to (c) is preferably 1 ⁇ m or more and 20 ⁇ m or less, more preferably 2 ⁇ m or more and 15 ⁇ m or less, still more preferably 2 ⁇ m or more and 12 ⁇ m or less, still more preferably 3 ⁇ m or more and 10 ⁇ m or less, still more preferably.
  • the aspect ratios of the components (a) to (c) are preferably 10 or more and 200 or less, more preferably 10 or more and 150 or less, still more preferably 10 or more and 100 or less, still more preferably 20 or more and 100 or less, still more preferably 30.
  • the external preparation for skin according to any one of ⁇ 1> to ⁇ 5>, which is 100 or more, more preferably 35 or more and 90 or less.
  • the compounding ratio of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total compounding amount of the components (a) to (c) satisfies the following condition 1, and preferably the following condition 2 is further satisfied.
  • Condition 1 In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
  • the total amount of the components (a) to (c) in the external preparation for skin is preferably 1% by mass or more and 35% by mass or less, more preferably 1% by mass or more and 25% by mass or less, and further preferably 1% by mass or more and 20% by mass.
  • % Or less more preferably 1% by mass or more and 15% by mass or less, still more preferably 1.5% by mass or more and 10% by mass or less, still more preferably 2% by mass or more and 10% by mass or less, ⁇ 1> to An external preparation for skin according to any one of ⁇ 7>.
  • the external preparation for skin according to any one of ⁇ 1> to ⁇ 8>, which further contains a feel-improving agent as the component (d).
  • the component (d) is preferably spherical inorganic particles, more preferably spherical metal oxide particles, and further preferably one or more selected from the group consisting of spherical titanium oxide particles and spherical zinc oxide particles. More preferably, the external preparation for skin of ⁇ 9>, which is spherical titanium oxide particles.
  • the average particle size of the particles used as the component (d) is preferably 0.1 ⁇ m or more and 10 ⁇ m or less, more preferably 0.2 ⁇ m or more and 5 ⁇ m or less, and further preferably 0.5 ⁇ m or more and 2 ⁇ m or less, ⁇ 9> or ⁇ . 10> External skin preparation.
  • the content of the component (d) is preferably 1% by mass or more and 20% by mass or less, more preferably 1% by mass or more and 15% by mass or less, still more preferably 1% by mass or more and 10% by mass or less, still more preferably 1.
  • the external preparation for skin according to any one of ⁇ 9> to ⁇ 11>, which is 5% by mass or more and 10% by mass or less, more preferably 2% by mass or more and 10% by mass or less.
  • the mass ratio of the total amount of the components (a) to (c) to the component (d) [ ⁇ (a) + (b) + (c) ⁇ / (d)] is preferably 0.1 or more and 5 or less. , More preferably 0.2 or more and 3 or less, still more preferably 0.5 or more and 2 or less, still more preferably 0.5 or more and 1.5 or less, for external use of any one of ⁇ 9> to ⁇ 12>. Agent.
  • ⁇ 14> The external preparation for skin according to any one of ⁇ 1> to ⁇ 13>, which further contains an ultraviolet absorber as a component (e).
  • Ingredient (e) is preferably an oil-soluble organic ultraviolet absorber, more preferably 2-ethylhexyl paramethoxysilicate, 4-tert-butyl-4'-methoxydibenzoylmethane, octocrylene, dimethoxybenzylene dioxoimidazo.
  • the skin external preparation of ⁇ 14> which is one or more selected from the group consisting of hexyl diethylaminohydroxybenzoylbenzoate, and bisethylhexyloxyphenol methoxyphenyltriazine.
  • the content of the component (e) is preferably 0.2% by mass or more and 30% by mass or less, more preferably 1% by mass or more and 25% by mass or less, still more preferably 3% by mass or more and 20% by mass or less, still more preferably.
  • ⁇ 14> or ⁇ 15> external preparation for skin which is 5% by mass or more and 15% by mass or less.
  • the mass ratio of the total amount of the components (a) to (c) to the component (e) [ ⁇ (a) + (b) + (c) ⁇ / (e)] is preferably 0.1 or more and 5 or less. , More preferably 0.1 or more and 3 or less, still more preferably 0.2 or more and 1 or less, still more preferably 0.3 or more and 1 or less, still more preferably 0.3 or more and 0.5 or less, ⁇ 14>.
  • ⁇ 18> The external preparation for skin according to any one of ⁇ 1> to ⁇ 17>, which further contains an oil agent as a component (f) and preferably contains a non-volatile oil (f1).
  • the component (f1) is selected from one or more selected from the group consisting of ester oils, silicone oils, hydrocarbon oils, higher fatty acids, and higher alcohols, and more preferably selected from the group consisting of ester oils, silicone oils, and hydrocarbon oils.
  • external skin preparation which is one or more.
  • the content of the component (f1) is preferably 1% by mass or more and 99% by mass or less, more preferably 4% by mass or more and 90% by mass or less, still more preferably 8% by mass or more and 80% by mass or less, still more preferably 8% by mass. % Or more and 50% by mass or less, more preferably 8% by mass or more and 30% by mass or less, ⁇ 18> or ⁇ 19> for external use on the skin.
  • the mass ratio of the total amount of the components (a) to (c) to the component (f1) [ ⁇ (a) + (b) + (c) ⁇ / (f1)] is preferably 0.01 or more and 10 or less.
  • the mass ratio [(e) / (f1)] is preferably 0.01 or more and 10 or less, more preferably 0.02 or more and 5 or less, still more preferably 0.05 or more and 3 or less, still more preferably 0.1 or more.
  • the content of the component (f2) is preferably 1% by mass or more and 85% by mass or less, more preferably 5% by mass or more and 80% by mass or less, and further preferably 10% by mass or more and 75% by mass or less, ⁇ 23>.
  • External preparation for skin is preferably 1% by mass or more and 85% by mass or less, more preferably 5% by mass or more and 80% by mass or less, and further preferably 10% by mass or more and 75% by mass or less.
  • An external preparation for skin the following components (a) to (c): (A) Plate-shaped titanium oxide with a thickness of 100 nm or more and 120 nm or less, (B) Plate-shaped titanium oxide with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped titanium oxide with a thickness of 180 nm or more and 200 nm or less. It is made by blending The average particle size of the components (a) to (c) is 3 ⁇ m or more and 10 ⁇ m or less.
  • the blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass with respect to the total blending amount of the components (a) to (c) of 100% by mass. % Or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less.
  • An external preparation for skin wherein the total amount of the components (a) to (c) in the external preparation for skin is 2% by mass or more and 10% by mass or less.
  • An external preparation for skin the following components (a) to (c): (A) Plate-shaped titanium oxide with a thickness of 100 nm or more and 120 nm or less, (B) Plate-shaped titanium oxide with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped titanium oxide with a thickness of 180 nm or more and 200 nm or less. It is made by blending The average particle size of the components (a) to (c) is 3 ⁇ m or more and 10 ⁇ m or less.
  • the compounding ratio of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total compounding amount of the components (a) to (c) satisfies the following condition 1.
  • An external preparation for skin wherein the total amount of the components (a) to (c) in the external preparation for skin is 2% by mass or more and 10% by mass or less.
  • Condition 1 In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
  • (A, b, c) (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12), (57 , 33, 10) ⁇ 27>
  • An external preparation for skin the following components (a) to (c): (A) Plate-shaped titanium oxide with a thickness of 100 nm or more and 120 nm or less, (B) Plate-shaped titanium oxide with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped titanium oxide with a thickness of 180 nm or more and 200 nm or less. It is made by blending The average particle size of the components (a) to (c) is 3 ⁇ m or more and 10 ⁇ m or less.
  • the compounding ratio of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total compounding amount of the components (a) to (c) satisfies the following condition 2.
  • An external preparation for skin wherein the total amount of the components (a) to (c) in the external preparation for skin is 2% by mass or more and 10% by mass or less.
  • Condition 2 In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
  • (A, b, c) (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22), (42) , 43, 15) ⁇ 28>
  • one or more kinds of feel improvers selected from the group consisting of spherical titanium oxide particles and spherical zinc oxide particles are contained in an amount of 2% by mass or more and 10% by mass or less. It contains 5% by mass or more and 15% by mass or less of an oil-soluble organic ultraviolet absorber as the component (e).
  • ⁇ 29> The external preparation for skin according to any one of ⁇ 1> to ⁇ 28>, wherein the dosage form is liquid, gel-like, or cream-like.
  • ⁇ 31> A method for protecting the skin from infrared rays by applying the external preparation for skin according to any one of ⁇ 1> to ⁇ 30> to the skin.
  • ⁇ 32> The method of ⁇ 31>, wherein the infrared protection rate at a wavelength of 1500 nm is preferably 10% or more, more preferably 12% or more, still more preferably 15% or more.
  • the thickness of the plate-shaped titanium oxide used as the components (a) to (c) is accelerated by accelerating the components (a) to (c) using a scanning electron microscope (“VE-9800” manufactured by KEYENCE CORPORATION). It was obtained by observing under the conditions of voltage: 10 keV and observation magnification: 10,000 times, measuring the thickness of 50 particles in the observed image, and calculating the average value per number.
  • VE-9800 scanning electron microscope
  • the average particle size of the plate-shaped titanium oxide used as the components (a) to (c) and the spherical titanium oxide used as the component (d) is determined by a laser diffraction / scattering type particle size distribution measuring device (Horiba Seisakusho Co., Ltd.). Using LA920 ”), the average particle size was defined as the value of the median diameter (D50) measured with an aqueous dispersion having a relative refractive index of 2.0 and a particle size reference volume.
  • the aspect ratio of the plate-shaped titanium oxide used as the components (a) to (c) was calculated by (average particle size / thickness).
  • the value obtained by dividing the transmittance of the measurement sample by the transmittance of the control sample was defined as the transmittance X (%), and 100-X (%) was defined as the infrared protection rate. The larger this value is, the higher the infrared protection effect is.
  • Production Example 2 (Production of plate-shaped titanium oxide 2) As the untreated plate-shaped titanium oxide, "Featheleve PT-7801K” (thickness 134 nm, aspect ratio 95, average particle size 12.8 ⁇ m) manufactured by CQV was used instead of "Feathereve PT-7401K” manufactured by CQV. Except for this, the same treatment as in Production Example 1 was carried out to obtain plate-shaped titanium oxide 2 having a thickness of 134 nm, an aspect ratio of 64, and an average particle size of 8.6 ⁇ m.
  • Production Example 3 (Production of plate-shaped titanium oxide 3)
  • "Featheleve PT-7901K” thickness 191 nm, aspect ratio 58, average particle size 11.1 ⁇ m) manufactured by CQV was used instead of "Featheleve PT-7401K” manufactured by CQV. Except for this, the same treatment as in Production Example 1 was carried out to obtain plate-shaped titanium oxide 3 having a thickness of 191 nm, an aspect ratio of 44, and an average particle size of 8.5 ⁇ m.
  • Examples 1 to 12 and Comparative Examples 1 to 8 manufactured and evaluation of external preparations for skin
  • the ingredients shown in Table 1 were blended and mixed uniformly using a homogenizer to prepare a skin external preparation having the composition shown in Table 1.
  • the obtained external preparation for skin was evaluated by the above method.
  • the results are shown in Table 1.
  • the blending amount shown in Table 1 is the amount of the active ingredient (mass%) of each component.
  • the external preparations for skin of Examples 1 to 12 can have both an infrared ray protective effect and a natural color when applied to the skin.
  • Examples 1, 3, 4, 6, 8 and 9 in which the blending ratios of the components (a) to (c) satisfy the above condition 1 are more preferable because the overall evaluation is A or more, and the implementation satisfying the above condition 2.
  • Examples 4 and 6 have a comprehensive evaluation of A +, which is more preferable.
  • the external preparations for skin of Comparative Examples 1 to 8 did not have a sufficient effect in at least one of the infrared protective effect and the natural color when applied to the skin.
  • a +, A, B, C, D and D- shown in the three-phase diagram of FIG. 1 indicates the components (a) to (c) corresponding to the external preparations for skin of Examples 1 to 12 and Comparative Examples 1 to 8. ), The comprehensive evaluation is shown.
  • the external preparation for skin of the present invention has an excellent infrared protective effect, and when applied to the skin, redness and blueness are less likely to be recognized, and a natural color that blends in with the skin color can be obtained.
  • skin makeup It is useful as a fee.
  • the blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass or less with respect to the total blending amount of 100% by mass of the components (a) to (c).
  • Composition region 2 in which the blending amount of the component (c) is 5% by mass or more and 70% by mass or less Composition region satisfying condition 1

Abstract

This external preparation for skin is obtained by combining the following components (a) through (c): (a) a plate-like metal oxide having a thickness of 100 to 120 nm, (b) a plate- like metal oxide having a thickness of 125 to 145 nm, and (c) a plate-like metal oxide having a thickness of 180 to 200 nm. In terms of a total of 100 mass% of the amounts added of components (a) through (c) , the content of component (a) is 5 to 70 mass%, the content of component (b) is 15 to 75 mass%, and the content of component (c) is 5 to 70 mass%.

Description

皮膚外用剤Topical skin agent
 本発明は、皮膚外用剤に関する。 The present invention relates to an external preparation for skin.
 太陽光に対する皮膚防御の観点から、日焼け止め化粧料などの紫外線防御化粧料が知られている。一方で、近年は健康意識の高まりにより、赤外線に対する防御機能を有する皮膚外用剤が求められている。
 赤外線防御機能を有する皮膚外用剤に関して、例えば特許文献1(国際公開第2009/017104号)には、赤外線が皮膚の組織よりも深部の真皮や皮下組織まで到達することを阻害し、赤外線によるそれらの組織の損傷を防止する防止剤に関する技術として、酸化チタン粉末と酸化亜鉛粉末とからなる赤外線透過遮蔽剤を含有する生体組織の近赤外線損傷の防止剤が開示されている。また特許文献2(特開2017-95361号公報)には、優れた近赤外防御効果と高い透明性を両立した、酸化チタン粉末と酸化亜鉛粉末とからなる近赤外線防御化粧料組成物が開示されている。
From the viewpoint of skin protection against sunlight, UV protection cosmetics such as sunscreen cosmetics are known. On the other hand, in recent years, due to heightened health consciousness, there is a demand for external preparations for skin having a protective function against infrared rays.
Regarding external preparations for skin having an infrared protective function, for example, Patent Document 1 (International Publication No. 2009/017104) states that infrared rays prevent infrared rays from reaching deeper into the dermis and subcutaneous tissues than the tissues of the skin, and those by infrared rays. As a technique relating to an inhibitor for preventing tissue damage, an inhibitor for near-infrared damage to living tissue containing an infrared transmission shielding agent composed of titanium oxide powder and zinc oxide powder has been disclosed. Further, Patent Document 2 (Japanese Unexamined Patent Publication No. 2017-95361) discloses a near-infrared protective cosmetic composition composed of titanium oxide powder and zinc oxide powder, which has both excellent near-infrared protection effect and high transparency. Has been done.
 本発明は、下記[1]及び[2]に関する。
[1]下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状金属酸化物、
(b)厚さ125nm以上145nm以下の板状金属酸化物、及び
(c)厚さ180nm以上200nm以下の板状金属酸化物、
を配合してなり、該成分(a)~(c)の合計配合量100質量%に対し、成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、成分(c)の配合量が5質量%以上70質量%以下である皮膚外用剤。
[2]上記[1]に記載の皮膚外用剤を皮膚に塗布する皮膚の赤外線防御方法。
The present invention relates to the following [1] and [2].
[1] The following components (a) to (c):
(A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less,
(B) Plate-shaped metal oxides with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped metal oxides with a thickness of 180 nm or more and 200 nm or less.
The compounding amount of the component (a) is 5% by mass or more and 70% by mass or less, and the compounding amount of the component (b) is 100% by mass with respect to the total compounding amount of the components (a) to (c) of 100% by mass. An external preparation for skin having an amount of 15% by mass or more and 75% by mass or less and a blending amount of the component (c) of 5% by mass or more and 70% by mass or less.
[2] A method for protecting the skin from infrared rays by applying the external preparation for skin according to the above [1] to the skin.
皮膚外用剤における成分(a)~(c)の合計配合量100質量%中の、成分(a)、成分(b)及び成分(c)の質量%を示した三相図である。It is a three-phase diagram which showed mass% of component (a), component (b) and component (c) in 100 mass% of the total compounding amount of component (a)-(c) in the external preparation for skin.
発明の詳細な説明Detailed description of the invention
[皮膚外用剤]
 本発明の皮膚外用剤は、下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状金属酸化物、
(b)厚さ125nm以上145nm以下の板状金属酸化物、及び
(c)厚さ180nm以上200nm以下の板状金属酸化物、
を配合してなり、該成分(a)~(c)の合計配合量100質量%に対し、成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、成分(c)の配合量が5質量%以上70質量%以下である。
 本発明の皮膚外用剤は上記構成であることにより、赤外線防御効果に優れるとともに、皮膚に塗布した際に皮膚の色になじむ自然な色合いが得られるものとなる。
[Skin external preparation]
The external preparation for skin of the present invention contains the following components (a) to (c):
(A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less,
(B) Plate-shaped metal oxides with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped metal oxides with a thickness of 180 nm or more and 200 nm or less.
The compounding amount of the component (a) is 5% by mass or more and 70% by mass or less, and the compounding amount of the component (b) is 100% by mass with respect to the total compounding amount of the components (a) to (c) of 100% by mass. It is 15% by mass or more and 75% by mass or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less.
Since the external preparation for skin of the present invention has the above structure, it has an excellent infrared ray protection effect and can obtain a natural color that blends with the skin color when applied to the skin.
 皮膚防御のため、特許文献1及び2の開示技術よりも、赤外線防御機能をさらに向上させた皮膚外用剤が望まれている。さらに、皮膚外用剤の中でも皮膚化粧料としては、赤味や青味を呈すると皮膚に塗布した際に不自然な色合いになるため、皮膚の色になじむ色合いであることも求められる。
 本発明は、赤外線防御効果に優れ、且つ、皮膚に塗布した際に赤味や青味が認められにくく、皮膚の色になじむ自然な色合いが得られる皮膚外用剤を提供することに関する。
 
For skin protection, an external preparation for skin with further improved infrared protection function is desired rather than the disclosed techniques of Patent Documents 1 and 2. Further, among the external preparations for skin, as a skin cosmetic, if it exhibits redness or bluish color, it becomes an unnatural color when applied to the skin, so that it is also required to have a color that matches the color of the skin.
The present invention relates to an external preparation for skin that has an excellent infrared protection effect, is less likely to have redness or bluish color when applied to the skin, and can obtain a natural color that blends in with the skin color.
 本発明者らは、所定の厚さ範囲を有し、厚さが互いに異なる板状金属酸化物を所定の割合で組み合わせて配合した皮膚外用剤が上記課題を解決できることを見出した。 The present inventors have found that a skin external preparation containing a combination of plate-like metal oxides having a predetermined thickness range and different thicknesses in a predetermined ratio can solve the above-mentioned problems.
 本発明の皮膚外用剤は、赤外線防御効果に優れ、且つ、皮膚に塗布した際に赤味や青味が認められにくく、皮膚の色になじむ自然な色合いが得られるものであり、例えば皮膚化粧料として有用である。 The external preparation for skin of the present invention has an excellent infrared protective effect, and when applied to the skin, redness and blueness are less likely to be recognized, and a natural color that blends in with the skin color can be obtained. For example, skin makeup. It is useful as a fee.
 本発明において板状金属酸化物の厚さとは、板状金属酸化物粒子において最も短い軸の長さを意味する。
 本発明において赤外線とは、波長780nm~1mmの電磁波を意味する。このうち本発明の皮膚外用剤は、特に、波長780nm~2500nmの近赤外線防御効果に優れる。これにより太陽光照射による皮膚温度の上昇を抑え、高い遮熱実感を得ることができる。
 なお本明細書においては、赤外線防御効果として波長1500nmの赤外線防御率を指標とする。
In the present invention, the thickness of the plate-shaped metal oxide means the length of the shortest shaft of the plate-shaped metal oxide particles.
In the present invention, infrared rays mean electromagnetic waves having a wavelength of 780 nm to 1 mm. Of these, the external preparation for skin of the present invention is particularly excellent in the near-infrared ray protection effect having a wavelength of 780 nm to 2500 nm. As a result, it is possible to suppress an increase in skin temperature due to sunlight irradiation and obtain a high feeling of heat insulation.
In this specification, the infrared protection rate with a wavelength of 1500 nm is used as an index as the infrared protection effect.
 本発明の皮膚外用剤の剤型は特に制限されないが、皮膚への塗布しやすさの点から、液状、ゲル状、又はクリーム状であることが好ましい。皮膚外用剤は乳化組成物の形態であってもよく、乳化組成物としては水中油型乳化組成物、油中水型乳化組成物のいずれでもよい。
 また本発明の皮膚外用剤は、日焼け止め化粧料(化粧水、クリーム、乳液、美容液等)、サンタン、化粧下地化粧料等の皮膚化粧料であることが好ましい。
The dosage form of the external preparation for skin of the present invention is not particularly limited, but it is preferably liquid, gel-like, or cream-like from the viewpoint of ease of application to the skin. The external preparation for skin may be in the form of an emulsified composition, and the emulsified composition may be either an oil-in-water emulsified composition or a water-in-oil emulsified composition.
Further, the external skin preparation of the present invention is preferably a skin cosmetic such as a sunscreen cosmetic (skin water, cream, milky lotion, beauty essence, etc.), suntan, makeup base cosmetic, and the like.
<成分(a)~(c):板状金属酸化物>
 本発明の皮膚外用剤は、下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状金属酸化物、
(b)厚さ125nm以上145nm以下の板状金属酸化物、及び
(c)厚さ180nm以上200nm以下の板状金属酸化物、を配合してなる。
 本発明の皮膚外用剤は成分(a)~(c)として上記所定の板状金属酸化物を所定割合で配合することにより、赤外線防御効果に優れ、高い遮熱実感が得られるとともに、白くなりにくく、且つ皮膚に塗布した際に皮膚の色になじむ自然な色合いが得られるという効果も奏する。この理由については定かではないが、以下のように考えられる。
<Components (a) to (c): Plate-like metal oxide>
The external preparation for skin of the present invention contains the following components (a) to (c):
(A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less,
(B) A plate-shaped metal oxide having a thickness of 125 nm or more and 145 nm or less, and (c) a plate-shaped metal oxide having a thickness of 180 nm or more and 200 nm or less are blended.
By blending the above-mentioned predetermined plate-shaped metal oxides as the components (a) to (c) in a predetermined ratio, the external preparation for skin of the present invention has an excellent infrared protection effect, a high heat-shielding feeling can be obtained, and the skin becomes white. It is difficult to use, and when applied to the skin, it also has the effect of obtaining a natural color that blends in with the skin color. The reason for this is not clear, but it can be considered as follows.
 酸化チタン等の無機粒子を含有する皮膚外用剤においては、粒子径が大きいものを用いた方が赤外線防御効果も高くなることが知られている。しかしながら、単に粒子径が大きい無機粒子を用いるだけでは赤外線防御効果の向上に限界があった。また、例えば球状無機粒子であって粒子径が可視光の波長よりも大きいものを皮膚外用剤に配合した場合、皮膚に塗布した際に、粒子表面で可視光の光散乱が生じるために白くなりやすいという欠点があった。
 これに対し、本発明者らは皮膚外用剤において、赤外線防御剤として所定の厚さの板状金属酸化物を用いることで、光の干渉効果により赤外線領域の光の反射率を選択的に高めながら、可視領域の光の反射率を低減することができ、これにより赤外線防御効果と、皮膚に塗布した際に白くなりにくいという効果とを両立できることを見出した。
 一方で、赤外線防御剤として板状金属酸化物を配合した皮膚外用剤は、皮膚に塗布した際に赤味や青味が認められるなどして、皮膚になじまない不自然な色合いになる場合があることが見出された。このような課題に対し、本発明者らは、厚さが互いに異なる板状金属酸化物である成分(a)~(c)を前記所定の割合で配合することにより、高い赤外線防御効果と、皮膚に塗布した際の自然な色合いとを両立できることを見出した。色合いに関しては、成分(a)~(c)は反射光の波長に由来してそれぞれ赤色、青色、及び緑色の干渉色を呈するが、各成分の配合量を所定の範囲とすることで、皮膚に塗布した際に皮膚の色になじむ自然な色合いを得ることができたものと考えられる。
It is known that, among skin external preparations containing inorganic particles such as titanium oxide, the one having a large particle size has a higher infrared protection effect. However, there is a limit to the improvement of the infrared protection effect simply by using inorganic particles having a large particle size. Further, for example, when spherical inorganic particles having a particle size larger than the wavelength of visible light are blended in an external preparation for skin, when applied to the skin, the particles become white due to light scattering of visible light on the surface of the particles. It had the drawback of being easy.
On the other hand, the present inventors selectively increase the reflectance of light in the infrared region by the interference effect of light by using a plate-shaped metal oxide having a predetermined thickness as an infrared protective agent in an external preparation for skin. However, it has been found that the reflectance of light in the visible region can be reduced, which makes it possible to achieve both an infrared protection effect and an effect of preventing whitening when applied to the skin.
On the other hand, an external preparation for skin containing a plate-like metal oxide as an infrared protective agent may have an unnatural color that does not blend with the skin, such as redness and blueness being observed when applied to the skin. It was found that there is. In response to such a problem, the present inventors have achieved a high infrared protection effect by blending the components (a) to (c), which are plate-shaped metal oxides having different thicknesses, in the predetermined ratios. We have found that it is compatible with the natural color when applied to the skin. Regarding the hue, the components (a) to (c) exhibit red, blue, and green interference colors, respectively, due to the wavelength of the reflected light. However, by setting the blending amount of each component within a predetermined range, the skin It is probable that a natural shade that blends in with the skin color could be obtained when applied to.
 上述した作用機構により優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点から、成分(a)~(c)の厚さは、それぞれ下記範囲であることが好ましい。
 成分(a)の厚さは、100nm以上、好ましくは105nm以上であり、120nm以下、好ましくは115nm以下である。厚さが上記範囲である成分(a)は、反射光の波長に由来して赤みがかった干渉色を呈する。
 成分(b)の厚さは、125nm以上、好ましくは130nm以上であり、145nm以下、好ましくは140nm以下である。厚さが上記範囲である成分(b)は、反射光の波長に由来して青みがかった干渉色を呈する。
 また成分(c)の厚さは、180nm以上、好ましくは185nm以上であり、200nm以下、好ましくは195nm以下である。厚さが上記範囲である成分(c)は、反射光の波長に由来して緑がかった干渉色を呈する。
 成分(a)~(c)の厚さは、いずれも走査電子顕微鏡(SEM)による観察画像から求めることができる。具体的には、成分(a)~(c)である板状金属酸化物をSEMにより観察倍率10,000倍の条件にて観察し、観察画像中の50個の粒子の厚さを測定して、個数あたりの厚さの平均値を算出することにより求められる。成分(a)~(c)の厚さは、具体的には実施例に記載の方法で測定できる。
The thickness of the components (a) to (c) from the viewpoint of obtaining an excellent infrared protection effect by the above-mentioned action mechanism, and from the viewpoint of obtaining a natural color without becoming white when the external preparation for skin is applied to the skin. Is preferably in the following range, respectively.
The thickness of the component (a) is 100 nm or more, preferably 105 nm or more, 120 nm or less, preferably 115 nm or less. The component (a) having a thickness in the above range exhibits a reddish interference color due to the wavelength of the reflected light.
The thickness of the component (b) is 125 nm or more, preferably 130 nm or more, and 145 nm or less, preferably 140 nm or less. The component (b) having a thickness in the above range exhibits a bluish interference color due to the wavelength of the reflected light.
The thickness of the component (c) is 180 nm or more, preferably 185 nm or more, and 200 nm or less, preferably 195 nm or less. The component (c) having a thickness in the above range exhibits a greenish interference color due to the wavelength of the reflected light.
The thicknesses of the components (a) to (c) can all be determined from the observation image by the scanning electron microscope (SEM). Specifically, the plate-shaped metal oxides of the components (a) to (c) are observed by SEM under the condition of an observation magnification of 10,000 times, and the thickness of 50 particles in the observation image is measured. Therefore, it is obtained by calculating the average value of the thickness per number. Specifically, the thicknesses of the components (a) to (c) can be measured by the method described in Examples.
 皮膚外用剤を皮膚に塗布した際にぎらつきを少なくする観点から、成分(a)~(c)の平均粒径は、好ましくは20μm以下、より好ましくは15μm以下、更に好ましくは12μm以下、より更に好ましくは10μm以下である。一方、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点から、成分(a)~(c)の平均粒径は、好ましくは1μm以上、より好ましくは2μm以上、更に好ましくは3μm以上、より更に好ましくは5μm以上である。成分(a)~(c)の平均粒径の具体的範囲は、好ましくは1μm以上20μm以下、より好ましくは2μm以上15μm以下、更に好ましくは2μm以上12μm以下、より更に好ましくは3μm以上10μm以下、より更に好ましくは5μm以上10μm以下である。
 成分(a)~(c)の平均粒径は、レーザー回折/散乱式粒度分布測定装置を用いて粒子径基準体積にて測定されるメディアン径(D50)であり、具体的には実施例に記載の方法で測定できる。
From the viewpoint of reducing glare when the external preparation for skin is applied to the skin, the average particle size of the components (a) to (c) is preferably 20 μm or less, more preferably 15 μm or less, still more preferably 12 μm or less, and further. It is preferably 10 μm or less. On the other hand, the average particle size of the components (a) to (c) is determined from the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of obtaining a natural color tone without becoming white when an external preparation for skin is applied to the skin. It is preferably 1 μm or more, more preferably 2 μm or more, still more preferably 3 μm or more, still more preferably 5 μm or more. The specific range of the average particle size of the components (a) to (c) is preferably 1 μm or more and 20 μm or less, more preferably 2 μm or more and 15 μm or less, still more preferably 2 μm or more and 12 μm or less, still more preferably 3 μm or more and 10 μm or less. Even more preferably, it is 5 μm or more and 10 μm or less.
The average particle size of the components (a) to (c) is a median diameter (D50) measured at a particle size reference volume using a laser diffraction / scattering type particle size distribution measuring device. It can be measured by the method described.
 また、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に自然な色合いを得る観点から、成分(a)~(c)のアスペクト比は、好ましくは10以上、より好ましくは20以上、更に好ましくは30以上、より更に好ましくは35以上である。また、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つぎらつきを少なくする観点から、好ましくは200以下、より好ましくは150以下、更に好ましくは100以下、より更に好ましくは90以下である。成分(a)~(c)のアスペクト比の具体的範囲は、好ましくは10以上200以下、より好ましくは10以上150以下、更に好ましくは10以上100以下、より更に好ましくは20以上100以下、より更に好ましくは30以上100以下、より更に好ましくは35以上90以下である。
 成分(a)~(c)のアスペクト比は、(平均粒径/厚さ)から算出できる。
Further, from the viewpoint of obtaining an excellent infrared protection effect and obtaining a natural color when the external preparation for skin is applied to the skin, the aspect ratios of the components (a) to (c) are preferably 10 or more. It is preferably 20 or more, more preferably 30 or more, and even more preferably 35 or more. Further, from the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of preventing whitening and reducing glare when the external preparation for skin is applied to the skin, it is preferably 200 or less, more preferably 150 or less, still more preferably. It is 100 or less, more preferably 90 or less. The specific range of the aspect ratios of the components (a) to (c) is preferably 10 or more and 200 or less, more preferably 10 or more and 150 or less, still more preferably 10 or more and 100 or less, still more preferably 20 or more and 100 or less, and more. It is more preferably 30 or more and 100 or less, and even more preferably 35 or more and 90 or less.
The aspect ratios of the components (a) to (c) can be calculated from (average particle size / thickness).
 皮膚外用剤を皮膚に塗布した際のぎらつきの度合いは、皮膚外用剤を塗布して得られる塗膜について、グロス値測定装置を用いて角度60°でのグロス値を測定することにより評価することができる。 The degree of glare when the external preparation for skin is applied to the skin is evaluated by measuring the gloss value at an angle of 60 ° using a gloss value measuring device for the coating film obtained by applying the external preparation for skin. Can be done.
 成分(a)~(c)を構成する金属酸化物は、高屈折率材料である方が高い光干渉効果が得られる。この観点から、成分(a)~(c)を構成する好ましい金属酸化物としては、酸化チタン、酸化亜鉛、酸化ジルコニウム、酸化鉄、酸化アルミニウム、酸化セリウム等が挙げられる。これらの中でも、好ましくは酸化チタン及び酸化亜鉛からなる群から選ばれる1種以上であり、より好ましくは酸化チタンである。すなわち、成分(a)~(c)は好ましくは板状酸化チタン及び板状酸化亜鉛からなる群から選ばれる1種以上であり、より好ましくは板状酸化チタンである。
 酸化チタンの結晶構造は、ルチル型、アナターゼ型、アモルファスのいずれでもよいが、優れた赤外線防御効果及び遮熱実感を得る観点からはルチル型が好ましい。
As the metal oxides constituting the components (a) to (c), a material having a high refractive index can obtain a higher optical interference effect. From this point of view, preferable metal oxides constituting the components (a) to (c) include titanium oxide, zinc oxide, zirconium oxide, iron oxide, aluminum oxide, cerium oxide and the like. Among these, one or more selected from the group consisting of titanium oxide and zinc oxide is preferable, and titanium oxide is more preferable. That is, the components (a) to (c) are preferably one or more selected from the group consisting of plate-shaped titanium oxide and plate-shaped zinc oxide, and more preferably plate-shaped titanium oxide.
The crystal structure of titanium oxide may be rutile type, anatase type, or amorphous, but the rutile type is preferable from the viewpoint of obtaining an excellent infrared protection effect and a feeling of heat shielding.
 成分(a)~(c)にかかる板状金属酸化物は、表面処理されていないものでもよく、皮膚外用剤への分散性を高めるために、必要に応じて公知の方法で疎水性処理等の表面処理を行ったものでもよい。なお、成分(a)~(c)にかかる板状金属酸化物は、金属酸化物以外の粒子の表面を金属酸化物で表面処理したものとは区別される。 The plate-shaped metal oxides of the components (a) to (c) may not be surface-treated, and may be treated with a hydrophobic treatment by a known method, if necessary, in order to enhance the dispersibility in the external preparation for skin. It may be the one which has been subjected to the surface treatment of. The plate-shaped metal oxides of the components (a) to (c) are distinguished from those in which the surface of particles other than the metal oxide is surface-treated with the metal oxide.
 成分(a)~(c)にかかる板状金属酸化物の表面処理に用いられる表面処理剤としては、シリコーン;アルキルアルコキシシラン;パーフルオロアルキルリン酸エステル、パーフルオロアルコール等のフッ素含有化合物;N-アシルグルタミン酸等のアミノ酸;その他、レシチン;金属石鹸;ステアリン酸等の脂肪酸;アルキルリン酸エステル等が挙げられる。これらの中でも、成分(a)~(c)の外用剤中への分散性を高める観点から、シリコーン及びアルキルアルコキシシランからなる群から選ばれる1種以上が好ましい。
 表面処理剤としてのシリコーンは特に制限されないが、例えば、メチルポリシロキサン、ジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン、メチルシクロポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、オクタメチルトリシロキサン、テトラデカメチルヘキサシロキサン、ジメチルシロキサン・メチル(ポリオキシエチレン)シロキサン・メチル(ポリオキシプロピレン)シロキサン共重合体、ジメチルシロキサン・メチル(ポリオキシエチレン)シロキサン共重合体、ジメチルシロキサン・メチル(ポリオキシプロピレン)シロキサン共重合体、ジメチルシロキサン・メチルセチルオキシシロキサン共重合体、ジメチルシロキサン・メチルステアロキシシロキサン共重合体、(アクリル酸アルキル/ジメチコン)コポリマー等の各種シリコーン油を挙げることができる。
 表面処理剤としてのアルキルアルコキシシランとしては、炭素数6以上20以下の、分岐又は直鎖のアルキル基を有するものが好ましく、例えばオクチルトリエトキシシラン、オクチルトリメトキシシランを挙げることができる。
 赤外線防御効果を向上させる観点からは、表面処理剤としてはメチルポリシロキサン、ジメチルポリシロキサン、メチルハイドロジェンポリシロキサン、(アクリル酸アルキル/ジメチコン)コポリマー、及びオクチルトリエトキシシランからなる群から選ばれる1種以上が好ましい。
Examples of the surface treatment agent used for the surface treatment of the plate-shaped metal oxides according to the components (a) to (c) include silicone; alkylalkoxysilane; fluorine-containing compounds such as perfluoroalkyl phosphate and perfluoroalcohol; N. -Amino acids such as acylglutamic acid; other examples include lecithin; metal soap; fatty acids such as stearic acid; alkyl phosphates and the like. Among these, one or more selected from the group consisting of silicone and alkylalkoxysilane is preferable from the viewpoint of enhancing the dispersibility of the components (a) to (c) in the external preparation.
Silicone as a surface treatment agent is not particularly limited, and for example, methylpolysiloxane, dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, methylcyclopolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, etc. Dodecamethylcyclohexasiloxane, octamethyltrisiloxane, tetradecamethylhexasiloxane, dimethylsiloxane / methyl (polyoxyethylene) siloxane / methyl (polyoxypropylene) siloxane copolymer, dimethylsiloxane / methyl (polyoxyethylene) siloxane Various types such as polymers, dimethylsiloxane / methyl (polyoxypropylene) siloxane copolymers, dimethylsiloxane / methylcetyloxysiloxane copolymers, dimethylsiloxane / methylstealoxysiloxane copolymers, (alkyl acrylate / dimethicone) copolymers, etc. Siloxane oil can be mentioned.
As the alkylalkoxysilane as the surface treatment agent, those having a branched or linear alkyl group having 6 to 20 carbon atoms are preferable, and examples thereof include octyltriethoxysilane and octyltrimethoxysilane.
From the viewpoint of improving the infrared protection effect, the surface treatment agent is selected from the group consisting of methylpolysiloxane, dimethylpolysiloxane, methylhydrogenpolysiloxane, (alkyl acrylate / dimethicone) copolymer, and octylriethoxysilane1. More than a seed is preferred.
 本発明の皮膚外用剤において、成分(a)~(c)の合計配合量100質量%に対する成分(a)の配合量は5質量%以上70質量%以下であり、成分(b)の配合量は15質量%以上75質量%以下であり、成分(c)の配合量は5質量%以上70質量%以下である。成分(a)~(c)の合計配合量100質量%に対する各成分の配合量が上記範囲であると、優れた赤外線防御効果と、皮膚外用剤を皮膚に塗布した際の自然な色合いとを両立できる。中でも赤外線防御効果に関しては、成分(a)~(c)の合計配合量100質量%に対する成分(a)の配合量を70質量%以下とした場合に、優れた赤外線防御効果が得られることが見出された。 In the external preparation for skin of the present invention, the blending amount of the component (a) is 5% by mass or more and 70% by mass or less with respect to 100% by mass of the total blending amount of the components (a) to (c), and the blending amount of the component (b). Is 15% by mass or more and 75% by mass or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less. When the blending amount of each component with respect to the total blending amount of the components (a) to (c) is within the above range, an excellent infrared ray protection effect and a natural color when the external preparation for skin is applied to the skin can be obtained. It is compatible. Above all, regarding the infrared protection effect, when the blending amount of the component (a) is 70% by mass or less with respect to the total blending amount of the components (a) to (c) of 100% by mass, an excellent infrared protection effect can be obtained. Found.
 本発明の皮膚外用剤は、優れた赤外線防御効果と、皮膚外用剤を皮膚に塗布した際の自然な色合いとを両立する観点から、成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の配合割合が以下の条件1を満たすことが好ましく、更に、以下の条件2を満たすことがより好ましい。
 条件1:成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の質量%を示した三相図において、各成分の配合割合が、下記で示した6組成点で囲まれた組成領域の範囲内である。
 (a,b,c)=(70,15,15)、(28,26,46)、(5,40,55)、(5,67,28)、(20,68,12)、(57,33,10)
 条件2:成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の質量%を示した三相図において、各成分の配合割合が、下記で示した6組成点で囲まれた組成領域の範囲内である。
 (a,b,c)=(50,28,22)、(25,45,30)、(25,32,43)、(15,43,42)、(23,55,22)、(42,43,15)
The skin external preparation of the present invention has a total blending amount of 100% by mass of the components (a) to (c) from the viewpoint of achieving both an excellent infrared protection effect and a natural color when the skin external preparation is applied to the skin. It is preferable that the blending ratio of the component (a), the component (b) and the component (c) with respect to the above condition 1 satisfies the following condition 1, and more preferably the following condition 2 is satisfied.
Condition 1: In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
(A, b, c) = (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12), (57 , 33, 10)
Condition 2: In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
(A, b, c) = (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22), (42) , 43, 15)
 上記条件1及び条件2について、図面を参照して説明する。
 図1は皮膚外用剤における成分(a)~(c)の合計配合量100質量%中の、成分(a)、成分(b)及び成分(c)の質量%を示した三相図である。図1の三相図において、太線実線で囲まれた領域1は、成分(a)~(c)の合計配合量100質量%に対する成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、且つ成分(c)の配合量が5質量%以上70質量%以下となる組成領域を示す。
 図1の三相図において破線で囲まれた領域2は、前記条件1を満たす組成領域である。図1において、(a,b,c)=(70,15,15)、(28,26,46)、(5,40,55)、(5,67,28)、(20,68,12)、(57,33,10)の6組成点を“〇”で表示した。
 図1の三相図において一点鎖線で囲まれた領域3は、前記条件2を満たす組成領域である。図1において、(a,b,c)=(50,28,22)、(25,45,30)、(25,32,43)、(15,43,42)、(23,55,22)、(42,43,15)の6組成点を“△”で表示した。
The above conditions 1 and 2 will be described with reference to the drawings.
FIG. 1 is a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) in the total blending amount of the components (a) to (c) in the external preparation for skin of 100% by mass. .. In the three-phase diagram of FIG. 1, in the region 1 surrounded by the thick solid line, the blending amount of the component (a) is 5% by mass or more and 70% by mass or less with respect to the total blending amount of 100% by mass of the components (a) to (c). , The composition region in which the blending amount of the component (b) is 15% by mass or more and 75% by mass or less and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less is shown.
The region 2 surrounded by the broken line in the three-phase diagram of FIG. 1 is a composition region satisfying the above condition 1. In FIG. 1, (a, b, c) = (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12). ) And (57, 33, 10) are indicated by "○".
The region 3 surrounded by the alternate long and short dash line in the three-phase diagram of FIG. 1 is a composition region that satisfies the above condition 2. In FIG. 1, (a, b, c) = (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22). ) And (42, 43, 15) are indicated by “Δ”.
 本発明の皮膚外用剤における成分(a)~(c)の合計配合量は、優れた赤外線防御効果を得る観点から、好ましくは1質量%以上、より好ましくは1.5質量%以上、更に好ましくは2質量%以上である。また、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点、並びに経済性の観点から、好ましくは35質量%以下、より好ましくは25質量%以下、更に好ましくは20質量%以下、より更に好ましくは15質量%以下、より更に好ましくは10質量%以下である。本発明の皮膚外用剤における成分(a)~(c)の合計配合量の具体的範囲は、好ましくは1質量%以上35質量%以下、より好ましくは1質量%以上25質量%以下、更に好ましくは1質量%以上20質量%以下、より更に好ましくは1質量%以上15質量%以下、より更に好ましくは1.5質量%以上10質量%以下、より更に好ましくは2質量%以上10質量%以下である。 The total amount of the components (a) to (c) in the external preparation for skin of the present invention is preferably 1% by mass or more, more preferably 1.5% by mass or more, still more preferably, from the viewpoint of obtaining an excellent infrared protection effect. Is 2% by mass or more. Further, from the viewpoint of obtaining a natural color that does not easily turn white when the external preparation for skin is applied to the skin and from the viewpoint of economy, it is preferably 35% by mass or less, more preferably 25% by mass or less, still more preferably 20. It is mass% or less, more preferably 15 mass% or less, still more preferably 10 mass% or less. The specific range of the total blending amount of the components (a) to (c) in the external preparation for skin of the present invention is preferably 1% by mass or more and 35% by mass or less, more preferably 1% by mass or more and 25% by mass or less, still more preferably. Is 1% by mass or more and 20% by mass or less, more preferably 1% by mass or more and 15% by mass or less, further preferably 1.5% by mass or more and 10% by mass or less, still more preferably 2% by mass or more and 10% by mass or less. Is.
 本発明の皮膚外用剤は、成分(a)~(c)以外の板状金属酸化物を配合することを排除するものではないが、本発明の効果を得る観点からは、その配合量は少ないことが好ましい。具体的には、皮膚外用剤に配合される板状金属酸化物の全量中の成分(a)~(c)の割合は、好ましくは70質量%以上、より好ましくは80質量%以上、更に好ましくは90質量%以上、より更に好ましくは95質量%以上であり、また、100質量%以下である。 The external preparation for skin of the present invention does not exclude the addition of plate-shaped metal oxides other than the components (a) to (c), but the amount thereof is small from the viewpoint of obtaining the effects of the present invention. Is preferable. Specifically, the ratio of the components (a) to (c) in the total amount of the plate-shaped metal oxide blended in the external preparation for skin is preferably 70% by mass or more, more preferably 80% by mass or more, still more preferably. Is 90% by mass or more, more preferably 95% by mass or more, and 100% by mass or less.
 成分(a)~(c)として、市販の板状金属酸化物を用いることもできる。例えば、市販の板状酸化チタンとしてCQV社製「Featheleve PT-9001K」、「Featheleve PT-7001K」、「Featheleve PT-7401K」、「Featheleve PT-7801K」、「Featheleve PT-7901K」等が挙げられる。これらの板状酸化チタンについて、前記表面処理を行ったものを成分(a)~(c)として用いることがより好ましい。
 また、板状金属酸化物のアスペクト比又は平均粒径を前記範囲に調整するために、市販の板状金属酸化物又はその表面処理品を粉砕機により粉砕処理したものを成分(a)~(c)として用いてもよい。粉砕処理方法は特に限定されず、公知の方法を用いることができる。表面処理した板状金属酸化物を用いる場合は、粉砕処理は、表面処理前、及び表面処理後のいずれの段階で行ってもよい。
Commercially available plate-shaped metal oxides can also be used as the components (a) to (c). For example, as commercially available plate-shaped titanium oxide, CQV's "Featheleve PT-9001K", "Featheleve PT-7001K", "Featheleve PT-7401K", "Featheleve PT-7801K", "Featheleve PT-7901K" and the like can be mentioned. .. It is more preferable to use these plate-shaped titanium oxides that have undergone the surface treatment as the components (a) to (c).
Further, in order to adjust the aspect ratio or the average particle size of the plate-shaped metal oxide within the above range, commercially available plate-shaped metal oxide or a surface-treated product thereof is pulverized by a pulverizer, and the components (a) to ( It may be used as c). The pulverization treatment method is not particularly limited, and a known method can be used. When the surface-treated plate-shaped metal oxide is used, the pulverization treatment may be performed at any stage before the surface treatment and after the surface treatment.
<成分(d):感触向上剤>
 本発明の皮膚外用剤は、後述する油剤等を配合した場合に、皮膚に塗布した際のべたつきを抑制してさらさらした良好な感触を得る観点から、さらに成分(d)として感触向上剤を含有することが好ましい。
 感触向上剤としては、有機粒子、前記成分(a)~(c)以外の無機粒子、及びこれらの混合物のいずれでもよく、通常、化粧料に配合されるものを使用できる。皮膚に塗布した際に良好な感触を得る観点から、粒子の形状としては球状が好ましい。また、粒子表面に凹凸を有するものや、多孔質のものを用いてもよい。
<Ingredient (d): Tactile improver>
The external preparation for skin of the present invention further contains a feel-improving agent as a component (d) from the viewpoint of suppressing stickiness when applied to the skin and obtaining a smooth and good feel when an oil agent or the like described later is blended. It is preferable to do so.
The feel improving agent may be any of organic particles, inorganic particles other than the above-mentioned components (a) to (c), and a mixture thereof, and those usually blended in cosmetics can be used. From the viewpoint of obtaining a good feel when applied to the skin, the shape of the particles is preferably spherical. Further, those having irregularities on the particle surface or those having a porous surface may be used.
 成分(d)として用いられる有機粒子としては、例えば、アクリル樹脂、シリコーン樹脂、ポリスチレン樹脂、ポリアミド樹脂、ポリエステル樹脂、ポリオレフィン樹脂、ポリスチレン樹脂、ポリウレタン樹脂、ビニル樹脂、尿素樹脂、フェノール樹脂、フッ素樹脂、メラミン樹脂、エポキシ樹脂、ポリカーボネート樹脂、アクリル-シリコーン共重合樹脂、アクリル-スチレン共重合樹脂、セルロース等の樹脂で構成された樹脂粒子が挙げられる。これらの樹脂粒子は、架橋型樹脂粒子でもよく、非架橋型樹脂粒子でもよい。
 前記成分(a)~(c)以外の無機粒子としては、金属酸化物粒子が好ましく、該金属酸化物としては、酸化チタン、酸化亜鉛、酸化ジルコニウム、酸化鉄、酸化アルミニウム、酸化セリウム等が挙げられる。これらの中でも、好ましくは酸化チタン及び酸化亜鉛からなる群から選ばれる1種以上であり、より好ましくは酸化チタンである。
Examples of the organic particles used as the component (d) include acrylic resin, silicone resin, polystyrene resin, polyamide resin, polyester resin, polyolefin resin, polystyrene resin, polyurethane resin, vinyl resin, urea resin, phenol resin, and fluororesin. Examples thereof include resin particles composed of resins such as melamine resin, epoxy resin, polycarbonate resin, acrylic-silicone copolymer resin, acrylic-styrene copolymer resin, and cellulose. These resin particles may be crosslinked resin particles or non-crosslinked resin particles.
Metal oxide particles are preferable as the inorganic particles other than the components (a) to (c), and examples of the metal oxide include titanium oxide, zinc oxide, zirconium oxide, iron oxide, aluminum oxide, and cerium oxide. Be done. Among these, one or more selected from the group consisting of titanium oxide and zinc oxide is preferable, and titanium oxide is more preferable.
 上記の中でも、成分(d)としては、好ましくは球状無機粒子であり、より好ましくは球状金属酸化物粒子であり、更に好ましくは球状酸化チタン粒子及び球状酸化亜鉛粒子からなる群から選ばれる1種以上であり、より更に好ましくは球状酸化チタン粒子である。 Among the above, the component (d) is preferably a spherical inorganic particle, more preferably a spherical metal oxide particle, and further preferably one selected from the group consisting of spherical titanium oxide particles and spherical zinc oxide particles. These are the above, and even more preferably, spherical titanium oxide particles.
 成分(d)として用いられる粒子の平均粒径は、皮膚に塗布した際のべたつきを抑制して良好な感触を得る観点から、好ましくは0.1μm以上、より好ましくは0.2μm以上、更に好ましくは0.5μm以上である。また、皮膚に塗布した際のべたつきを抑制して良好な感触を得る観点、及び皮膚外用剤を皮膚に塗布した際に白くなりにくいという観点から、好ましくは10μm以下、より好ましくは5μm以下、さらに好ましくは2μm以下である。成分(d)として用いられる粒子の平均粒径の具体的範囲は、好ましくは0.1μm以上10μm以下、より好ましくは0.2μm以上5μm以下、更に好ましくは0.5μm以上2μm以下である。当該平均粒径は、前記と同様の方法で測定できる。 The average particle size of the particles used as the component (d) is preferably 0.1 μm or more, more preferably 0.2 μm or more, still more preferably 0.2 μm or more, from the viewpoint of suppressing stickiness when applied to the skin and obtaining a good feel. Is 0.5 μm or more. Further, from the viewpoint of suppressing stickiness when applied to the skin to obtain a good feel, and from the viewpoint of preventing whitening when the external preparation for skin is applied to the skin, it is preferably 10 μm or less, more preferably 5 μm or less, and further. It is preferably 2 μm or less. The specific range of the average particle size of the particles used as the component (d) is preferably 0.1 μm or more and 10 μm or less, more preferably 0.2 μm or more and 5 μm or less, and further preferably 0.5 μm or more and 2 μm or less. The average particle size can be measured by the same method as described above.
 本発明の皮膚外用剤において成分(d)を用いる場合、その含有量は、皮膚に塗布した際のべたつきを抑制して良好な感触を得る観点から、皮膚外用剤中、好ましくは1質量%以上、より好ましくは1.5質量%以上、更に好ましくは2質量%以上である。また、皮膚に塗布した際のべたつきを抑制して良好な感触を得る観点、及び皮膚外用剤を皮膚に塗布した際に白くなりにくいという観点から、好ましくは20質量%以下、より好ましくは15質量%以下、更に好ましくは10質量%以下である。本発明の皮膚外用剤における成分(d)の含有量の具体的範囲は、好ましくは1質量%以上20質量%以下、より好ましくは1質量%以上15質量%以下、更に好ましくは1質量%以上10質量%以下、より更に好ましくは1.5質量%以上10質量%以下、より更に好ましくは2質量%以上10質量%以下である。 When the component (d) is used in the external preparation for skin of the present invention, its content is preferably 1% by mass or more in the external preparation for skin from the viewpoint of suppressing stickiness when applied to the skin and obtaining a good feel. , More preferably 1.5% by mass or more, still more preferably 2% by mass or more. Further, from the viewpoint of suppressing stickiness when applied to the skin to obtain a good feel, and from the viewpoint of preventing whitening when the external preparation for skin is applied to the skin, it is preferably 20% by mass or less, more preferably 15% by mass. % Or less, more preferably 10% by mass or less. The specific range of the content of the component (d) in the external preparation for skin of the present invention is preferably 1% by mass or more and 20% by mass or less, more preferably 1% by mass or more and 15% by mass or less, and further preferably 1% by mass or more. It is 10% by mass or less, more preferably 1.5% by mass or more and 10% by mass or less, and even more preferably 2% by mass or more and 10% by mass or less.
 本発明の皮膚外用剤において、成分(a)~(c)の合計配合量と成分(d)との質量比[{(a)+(b)+(c)}/(d)]は、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点から、好ましくは0.1以上、より好ましくは0.2以上、更に好ましくは0.5以上である。また、皮膚に塗布した際のべたつきを抑制して良好な感触を得る観点から、好ましくは5以下、より好ましくは3以下、更に好ましくは2以下、より更に好ましくは1.5以下である。質量比[{(a)+(b)+(c)}/(d)]の具体的範囲は、好ましくは0.1以上5以下、より好ましくは0.2以上3以下、更に好ましくは0.5以上2以下、より更に好ましくは0.5以上1.5以下である。 In the external preparation for skin of the present invention, the mass ratio [{(a) + (b) + (c)} / (d)] of the total amount of the components (a) to (c) and the component (d) is determined. From the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of obtaining a natural color tone that does not easily turn white when an external preparation for skin is applied to the skin, it is preferably 0.1 or more, more preferably 0.2 or more, and further. It is preferably 0.5 or more. Further, from the viewpoint of suppressing stickiness when applied to the skin and obtaining a good feel, it is preferably 5 or less, more preferably 3 or less, still more preferably 2 or less, still more preferably 1.5 or less. The specific range of the mass ratio [{(a) + (b) + (c)} / (d)] is preferably 0.1 or more and 5 or less, more preferably 0.2 or more and 3 or less, and further preferably 0. It is .5 or more and 2 or less, more preferably 0.5 or more and 1.5 or less.
<成分(e):紫外線吸収剤>
 本発明の皮膚外用剤は、赤外線防御効果に加えて紫外線防御効果を付与する観点から、さらに成分(e)として紫外線吸収剤を含有することが好ましい。
 成分(e)としては、有機紫外線吸収剤であることが好ましく、油溶性の有機紫外線吸収剤、又は水溶性の有機紫外線吸収剤を用いることができる。紫外線防御効果、皮膚に塗布した際の見た目の自然さ、塗布後の化粧のりのよさを得る観点、及びべたつき抑制の観点から、成分(e)は油溶性の有機紫外線吸収剤であることが好ましい。なお「油溶性」とは、非水溶性であることを意味し、具体的には水への溶解度が1w/w%以下であることをいう。
 なお、本発明の効果を得る観点から、成分(e)は、例えば無機充填材の表面を紫外線吸収性材料で被覆した紫外線吸収剤等の、無機系の紫外線吸収剤とは区別される。
<Component (e): UV absorber>
The external preparation for skin of the present invention preferably further contains an ultraviolet absorber as a component (e) from the viewpoint of imparting an ultraviolet protection effect in addition to the infrared protection effect.
As the component (e), an organic ultraviolet absorber is preferable, and an oil-soluble organic ultraviolet absorber or a water-soluble organic ultraviolet absorber can be used. The component (e) is preferably an oil-soluble organic UV absorber from the viewpoints of UV protection effect, natural appearance when applied to the skin, good cosmetic adhesion after application, and suppression of stickiness. .. The term "oil-soluble" means that it is water-insoluble, and specifically means that the solubility in water is 1 w / w% or less.
From the viewpoint of obtaining the effect of the present invention, the component (e) is distinguished from an inorganic ultraviolet absorber such as an ultraviolet absorber in which the surface of an inorganic filler is coated with an ultraviolet absorbing material.
 油溶性の有機紫外線吸収剤としては、サリチル酸系紫外線吸収剤、ケイ皮酸系紫外線吸収剤、ベンゾイルメタン系紫外線吸収剤、及びその他の有機紫外線吸収剤のうち油溶性のものを用いることができる。
 例えば、サリチル酸ホモメンチル、サリチル酸オクチル等のサリチル酸系紫外線吸収剤;
パラメトキシケイ皮酸2-エチルヘキシル(例えば、BASF製「ユビナールMC80」)、ジパラメトキシケイ皮酸モノ-2-エチルヘキサン酸グリセリル、2,5-ジイソプロピルケイ皮酸メチル、トリメトキシケイ皮酸メチルビス(トリメチルシロキシ)シリルイソペンチル、パラメトキシケイ皮酸イソプロピル・ジイソプロピルケイ皮酸エステル混合物等のケイ皮酸系紫外線吸収剤;
4-イソプロピルジベンゾイルメタン、4-tert-ブチル-4'-メトキシジベンゾイルメタン(例えば、DSMニュートリションジャパン社製「パラソール1789」)等のベンゾイルメタン系紫外線吸収剤;
オクトクリレン(例えば、DSMニュートリションジャパン社製「パラソール340」)、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2-エチルヘキシル(例えば、味の素(株)製「ソフトシェードDH」)、1-(3,4-ジメトキシフェニル)-4,4-ジメチル-1,3-ペンタンジオン、シノキサート、メチル-O-アミノベンゾエート、3-(4-メチルベンジリデン)カンフル、オクチルトリアゾン、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル(2-(4-ジエチルアミノ-2-ヒドロキシベンゾイル)安息香酸へキシルエステル、例えば、BASF製「ユビナールAplus」)、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン(2,4-ビス{[4-(2-エチルヘキシルオキシ)-2-ヒドロキシ]フェニル}-6-(4-メトキシフェニル)-1,3,5-トリアジン、例えば、BASF製「チノソーブS」)、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール(例えば、BASF製「チノソーブM」)、2,4,6-トリス[4-(2-エチルへキシルオキシカルボニル)アニリノ]-1,3,5-トリアジン(以下、「エチルヘキシルトリアゾン」ともいう。例えば、BASF製「ユビナールT150」);等が挙げられる。
As the oil-soluble organic UV absorber, an oil-soluble one among salicylic acid-based UV absorbers, cinnamic acid-based UV absorbers, benzoylmethane-based UV absorbers, and other organic UV absorbers can be used.
For example, salicylic acid-based UV absorbers such as homomentyl salicylate and octyl salicylate;
2-Ethylhexyl paramethoxycinnamate (for example, "Ubinal MC80" manufactured by BASF), glyceryl diparamethoxycinnamate mono-2-ethylhexanate, methyl 2,5-diisopropylsilicate, methylbis trimethoxycinnamate (Trimethylsiloxy) Cinnamic acid-based ultraviolet absorbers such as silylisopentyl and isopropyl-diisopropylsilicate ester mixture of paramethoxycinnamate;
Benzoylmethane-based UV absorbers such as 4-isopropyldibenzoylmethane and 4-tert-butyl-4'-methoxydibenzoylmethane (for example, "Parasol 1789" manufactured by DSM Nutrition Japan);
Octocrylene (for example, "Parasol 340" manufactured by DSM Nutrition Japan), 2-ethylhexyl dimethoxybenzylidene dioxoimidazolidine propionate (for example, "Soft Shade DH" manufactured by Ajinomoto Co., Ltd.), 1- (3,4-dimethoxyphenyl) ) -4,4-Dimethyl-1,3-pentandione, synoxate, methyl-O-aminobenzoate, 3- (4-methylbenzylidene) phenyl, octylriazone, hexyl diethylaminohydroxybenzoyl benzoate (2- (4- (4-4-methylbenzylidene)) Diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, eg, BASF "Ubinal Aplus"), bisethylhexyloxyphenol methoxyphenyltriazine (2,4-bis {[4- (2-ethylhexyloxy) -2-hydroxy) ] Phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine, eg, BASF "Tinosorb S"), methylenebisbenzotriazolyltetramethylbutylphenol (eg, BASF "Tinosorb M") , 2,4,6-Tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine (hereinafter, also referred to as "ethylhexyltriazone". For example, "Ubinal T150" manufactured by BASF). ; Etc. can be mentioned.
 水溶性の有機紫外線吸収剤としては、サリチル酸系紫外線吸収剤、ケイ皮酸系紫外線吸収剤、ベンゾイルメタン系紫外線吸収剤、及びその他の有機紫外線吸収剤のうち水への溶解度が1w/w%を超えるものを用いることができ、例えば、サリチル酸トリエタノールアミン塩、p-メトキシハイドロケイ皮酸ジエタノールアミン塩等が挙げられる。 As a water-soluble organic UV absorber, salicylic acid-based UV absorber, silicic acid-based UV absorber, benzoylmethane-based UV absorber, and other organic UV absorbers have a solubility in water of 1 w / w%. Those exceeding the above can be used, and examples thereof include salicylic acid triethanolamine salt, p-methoxyhydrosilicate diethanolamine salt and the like.
 上記の中でも、紫外線防御効果の観点から、成分(e)としてはパラメトキシケイ皮酸2-エチルヘキシル、4-tert-ブチル-4’-メトキシジベンゾイルメタン、オクトクリレン、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2-エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール、及び2,4,6-トリス[4-(2-エチルへキシルオキシカルボニル)アニリノ]-1,3,5-トリアジンからなる群から選ばれる1種以上が好ましく、パラメトキシケイ皮酸2-エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、及び2,4,6-トリス[4-(2-エチルへキシルオキシカルボニル)アニリノ]-1,3,5-トリアジンからなる群から選ばれる1種以上がより好ましい。更に好ましくは、パラメトキシケイ皮酸2-エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、及びビスエチルヘキシルオキシフェノールメトキシフェニルトリアジンからなる群から選ばれる1種以上である。 Among the above, from the viewpoint of ultraviolet protection effect, the component (e) includes 2-ethylhexyl paramethoxysilicate, 4-tert-butyl-4'-methoxydibenzoylmethane, octocrylene, and dimethoxybenzylidene dioxoimidazolidine propionic acid. 2-Ethylhexyl, diethylaminohydroxybenzoyl hexyl benzoate, bisethylhexyloxyphenol methoxyphenyltriazine, methylenebisbenzotriazolyltetramethylbutylphenol, and 2,4,6-tris [4- (2-ethylhexyloxycarbonyl) anilino ] -1,3,5-Triazine is preferably one or more selected from the group consisting of 2-ethylhexyl paramethoxysilicate, hexyl diethylaminohydroxybenzoylbenzoate, bisethylhexyloxyphenol methoxyphenyltriazine, and 2,4. More preferably, one or more selected from the group consisting of 6-tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine. More preferably, it is one or more selected from the group consisting of 2-ethylhexyl paramethoxycinnamate, hexyl diethylaminohydroxybenzoylbenzoate, and bisethylhexyloxyphenol methoxyphenyl triazine.
 本発明の皮膚外用剤において成分(e)を用いる場合、その含有量は、優れた紫外線防御効果を付与する観点から、皮膚外用剤中、好ましくは0.2質量%以上、より好ましくは1質量%以上、更に好ましくは3質量%以上、より更に好ましくは5質量%以上である。また、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点から、好ましくは30質量%以下、より好ましくは25質量%以下、更に好ましくは20質量%以下、より更に好ましくは15質量%以下である。皮膚外用剤中の成分(e)の含有量の具体的範囲は、好ましくは0.2質量%以上30質量%以下、より好ましくは1質量%以上25質量%以下、更に好ましくは3質量%以上20質量%以下、より更に好ましくは5質量%以上15質量%以下である。 When the component (e) is used in the external preparation for skin of the present invention, the content thereof is preferably 0.2% by mass or more, more preferably 1% by mass in the external preparation for skin from the viewpoint of imparting an excellent ultraviolet protection effect. % Or more, more preferably 3% by mass or more, still more preferably 5% by mass or more. Further, from the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of obtaining a natural color tone that is less likely to turn white when an external preparation for skin is applied to the skin, it is preferably 30% by mass or less, more preferably 25% by mass or less. , More preferably 20% by mass or less, and even more preferably 15% by mass or less. The specific range of the content of the component (e) in the external preparation for skin is preferably 0.2% by mass or more and 30% by mass or less, more preferably 1% by mass or more and 25% by mass or less, and further preferably 3% by mass or more. It is 20% by mass or less, more preferably 5% by mass or more and 15% by mass or less.
 本発明の皮膚外用剤において、成分(a)~(c)の合計配合量と成分(e)との質量比[{(a)+(b)+(c)}/(e)]は、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点から、好ましくは0.1以上、より好ましくは0.2以上、更に好ましくは0.3以上である。また、優れた紫外線防御効果を付与する観点から、好ましくは5以下、より好ましくは3以下、更に好ましくは1以下、より更に好ましくは0.5以下である。質量比[{(a)+(b)+(c)}/(e)]の具体的範囲は、好ましくは0.1以上5以下、より好ましくは0.1以上3以下、更に好ましくは0.2以上1以下、より更に好ましくは0.3以上1以下、より更に好ましくは0.3以上0.5以下である。 In the external preparation for skin of the present invention, the mass ratio [{(a) + (b) + (c)} / (e)] of the total amount of the components (a) to (c) and the component (e) is determined. From the viewpoint of obtaining an excellent infrared protection effect and from the viewpoint of obtaining a natural color tone that does not easily turn white when an external preparation for skin is applied to the skin, it is preferably 0.1 or more, more preferably 0.2 or more, and further. It is preferably 0.3 or more. Further, from the viewpoint of imparting an excellent UV protection effect, it is preferably 5 or less, more preferably 3 or less, still more preferably 1 or less, still more preferably 0.5 or less. The specific range of the mass ratio [{(a) + (b) + (c)} / (e)] is preferably 0.1 or more and 5 or less, more preferably 0.1 or more and 3 or less, and further preferably 0. .2 or more and 1 or less, more preferably 0.3 or more and 1 or less, still more preferably 0.3 or more and 0.5 or less.
<成分(f):油剤>
 本発明の皮膚外用剤は、成分(a)~(c)を分散させ、及び他の配合成分を分散又は溶解させて皮膚への塗布性を向上させる観点、並びに水中油型、又は油中水型の皮膚外用剤を調製する観点から、さらに成分(f)として油剤を含有することが好ましい。該油剤としては、前記成分(e)以外の不揮発性油(f1)及び揮発性油(f2)のいずれも用いることができ、これらを併用することもできる。本発明の皮膚外用剤において前述した成分(e)として油溶性の紫外線吸収剤を用いる場合、これを溶解させる観点から、油剤(f)は、少なくとも不揮発性油(f1)を含むことが好ましい。
<Component (f): Oil agent>
The external preparation for skin of the present invention has a viewpoint of improving the applicability to the skin by dispersing the components (a) to (c) and dispersing or dissolving other compounding components, as well as the oil-in-water type or water in oil. From the viewpoint of preparing a type of external preparation for skin, it is preferable to further contain an oil agent as the component (f). As the oil agent, either a non-volatile oil (f1) or a volatile oil (f2) other than the component (e) can be used, and these can also be used in combination. When an oil-soluble ultraviolet absorber is used as the above-mentioned component (e) in the external preparation for skin of the present invention, the oil agent (f) preferably contains at least a non-volatile oil (f1) from the viewpoint of dissolving the oil-soluble ultraviolet absorber.
(不揮発性油(f1))
 本発明の皮膚外用剤は、油剤(f)として不揮発性油(f1)を含有することが好ましい。不揮発性油とは、以下の方法(1)により測定される、25℃、6時間での蒸発量が20%未満のものをいう。
 方法(1):直径120mmのガラス製シャーレの中に、直径90mmの濾紙を入れ、濾紙にサンプルを1gのせて、65%RHの室内(25℃)に保存する。そして6時間後のサンプルの残留物を測定し、蒸発量を算出する。
(Non-volatile oil (f1))
The external preparation for skin of the present invention preferably contains a non-volatile oil (f1) as the oil (f). The non-volatile oil means an oil having an evaporation amount of less than 20% at 25 ° C. for 6 hours, which is measured by the following method (1).
Method (1): A filter paper having a diameter of 90 mm is placed in a glass petri dish having a diameter of 120 mm, 1 g of a sample is placed on the filter paper, and the sample is stored in a room (25 ° C.) at 65% RH. Then, the residue of the sample after 6 hours is measured, and the amount of evaporation is calculated.
 成分(f1)は1気圧下、25℃において液状であることが好ましい。より具体的には、成分(f1)は、25℃における粘度が好ましくは500mPa・s以下であり、より好ましくは300mPa・s以下であり、更に好ましくは100mPa・s以下であり、より更に好ましくは50mPa・s以下であり、好ましくは5mPa・s以上である。
 当該粘度は、B型粘度計「TVB-10」(東機産業(株)製)を用いて、ロータNo.1、25℃、60rpm、1分間の条件で測定できる。
The component (f1) is preferably liquid at 25 ° C. under 1 atm. More specifically, the component (f1) has a viscosity at 25 ° C. of preferably 500 mPa · s or less, more preferably 300 mPa · s or less, still more preferably 100 mPa · s or less, and even more preferably. It is 50 mPa · s or less, preferably 5 mPa · s or more.
The viscosity was determined by using a B-type viscometer "TVB-10" (manufactured by Toki Sangyo Co., Ltd.). It can be measured under the conditions of 1, 25 ° C., 60 rpm and 1 minute.
 成分(f1)の具体例としては、成分(e)以外の25℃で液状である不揮発性油であり、エステル油、シリコーン油、炭化水素油、高級脂肪酸、高級アルコールが挙げられる。 Specific examples of the component (f1) include non-volatile oils other than the component (e) that are liquid at 25 ° C., ester oils, silicone oils, hydrocarbon oils, higher fatty acids, and higher alcohols.
 不揮発性の液状のエステル油としては、例えば、イソノナン酸イソノニル、イソノナン酸イソトリデシル、ミリスチン酸イソプロピル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸エチルヘキシル、パルミチン酸2-ヘキシルデシル、トリ2-エチルヘキサン酸グリセリル、セバシン酸ジ2-エチルヘキシル、セバシン酸ジイソプロピル、トリ(カプリル酸/カプリン酸)グリセリル、リンゴ酸ジイソステアリル、ジカプリン酸ジエチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ2-エチルヘキサン酸ネオペンチルグリコール、及び安息香酸アルキル(C12~C15)等の安息香酸アルキルからなる群から選ばれる1種以上が挙げられる。 Examples of the non-volatile liquid ester oil include isononyl isononanoate, isotridecyl isononanoate, isopropyl myristate, isocetyl myristate, octyldodecyl myristate, isopropyl palmitate, ethylhexyl palmitate, 2-hexyldecyl palmitate, and tri2. -Glyceryl ethylhexanoate, di2-ethylhexyl sebacate, diisopropyl sebacate, tri (caprylic acid / capric acid) glyceryl, diisostearyl malate, diethylene glycol dicaprate, neopentyl glycol dicaprate, neo di2-ethylhexanoate One or more selected from the group consisting of pentylglycol and alkyl benzoate such as alkyl benzoate (C12 to C15) can be mentioned.
 上記の中でも、皮膚に塗布した際に自然な色合いを得る観点、及びべたつき抑制の観点から、炭素数12以上18以下の脂肪酸と炭素数2以上22以下の分岐アルコールとのモノエステル、炭素数6以上18以下の分岐脂肪酸とグリセリンとのトリエステル、炭素数2以上18以下のジカルボン酸と炭素数2以上18以下の分岐アルコールとのジエステル、炭素数6以上18以下の脂肪酸と炭素数2以上10以下の分岐ジアルコールとのジエステル、安息香酸アルキル(C12~C15)(例えば、フィンソルブTN;Innospec Active Chemicals LLC製)等が好ましく、具体的にはミリスチン酸イソプロピル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸エチルヘキシル、パルミチン酸2-ヘキシルデシル、トリ2-エチルヘキサン酸グリセリル、セバシン酸ジイソプロピル、セバシン酸ジ2-エチルヘキシル、リンゴ酸ジイソステアリル、ジ2-エチルヘキサン酸ネオペンチルグリコール、ジカプリン酸ネオペンチルグリコール、及び安息香酸アルキル(C12~C15)からなる群から選ばれる1種以上がより好ましく、パルミチン酸イソプロピル及び安息香酸アルキル(C12~C15)からなる群から選ばれる1種以上が更に好ましい。 Among the above, from the viewpoint of obtaining a natural color when applied to the skin and suppressing stickiness, a monoester of a fatty acid having 12 or more and 18 or less carbon atoms and a branched alcohol having 2 or more and 22 or less carbon atoms, and 6 carbon atoms. Triester of branched fatty acid of 18 or more and 18 or less and glycerin, diester of dicarboxylic acid of 2 or more and 18 or less carbon and branched alcohol of 2 or more and 18 or less carbon number, fatty acid of 6 or more and 18 or less carbon number and 2 or more and 10 carbon atoms Diesters with the following branched dialcohols, alkyl benzoates (C12 to C15) (for example, Finsolve TN; manufactured by Innospec Active Chemicals LLC) and the like are preferable, and specifically, isopropyl myristate, isosetyl myristate, octyldodecyl myristate, etc. Isopropyl palmitate, ethylhexyl palmitate, 2-hexyldecyl palmitate, glyceryl tri2-ethylhexanoate, diisopropyl sebacate, di2-ethylhexyl sebacate, diisostearyl malate, neopentyl glycol di2-ethylhexanate, One or more selected from the group consisting of neopentyl glycol dicaprate and alkyl benzoate (C12 to C15) is more preferable, and one or more selected from the group consisting of isopropyl palmitate and alkyl benzoate (C12 to C15) is more preferable. More preferred.
 不揮発性の液状のシリコーン油としては、皮膚に塗布した際のべたつき抑制の観点からメチルポリシロキサンが好ましく、25℃における粘度が20mPa・s以下のメチルポリシロキサンがより好ましい。 As the non-volatile liquid silicone oil, methylpolysiloxane is preferable from the viewpoint of suppressing stickiness when applied to the skin, and methylpolysiloxane having a viscosity at 25 ° C. of 20 mPa · s or less is more preferable.
 不揮発性の液状の炭化水素油としては、流動パラフィン、水添ポリイソブテン等の軽質流動イソパラフィン、重質流動イソパラフィン、流動オゾケライト、スクワラン、プリスタン、スクワレン、イソヘキサデカン等が挙げられる。これらのうち、皮膚に塗布した際のべたつき抑制の観点から好ましくは軽質流動イソパラフィン及びイソヘキサデカンからなる群から選ばれる1種以上であり、より好ましくは軽質流動イソパラフィンである。 Examples of non-volatile liquid hydrocarbon oils include liquid paraffin, light liquid isoparaffin such as hydrogenated polyisobutene, heavy liquid isoparaffin, liquid zokerite, squalane, pristane, squalene, and isohexadecane. Among these, one or more selected from the group consisting of light liquid isoparaffin and isohexadecane is preferable from the viewpoint of suppressing stickiness when applied to the skin, and more preferably light liquid isoparaffin.
 不揮発性の液状の高級脂肪酸としては、炭素数12以上22以下の脂肪酸が挙げられ、具体的には、オレイン酸、イソステアリン酸、リノール酸、リノレイン酸等が挙げられる。
 不揮発性の液状の高級アルコールとしては、例えば、炭素数12以上28以下のアルコールが挙げられ、具体的には、オレイルアルコール、2-デシルテトラデシノール、ドデカノール、イソステアリルアルコール、オクチルドデカノール等が挙げられる。
Examples of the non-volatile liquid higher fatty acid include fatty acids having 12 or more and 22 or less carbon atoms, and specific examples thereof include oleic acid, isostearic acid, linoleic acid, and linoleic acid.
Examples of the non-volatile liquid higher alcohol include alcohols having 12 to 28 carbon atoms, and specific examples thereof include oleyl alcohol, 2-decyltetradecinol, dodecanol, isostearyl alcohol, and octyldodecanol. Can be mentioned.
 成分(f1)は、25℃で液状である不揮発性油のうち、皮膚に塗布した際のべたつき抑制の観点から、好ましくはエステル油、シリコーン油及び炭化水素油からなる群から選ばれる1種以上であり、より好ましくはエステル油及び炭化水素油からなる群から選ばれる1種以上であり、更に好ましくは、安息香酸アルキル(C12~15)、パルミチン酸イソプロピル、及び軽質流動イソパラフィンからなる群から選ばれる1種以上である。 The component (f1) is one or more selected from the group consisting of ester oils, silicone oils and hydrocarbon oils, preferably from the viewpoint of suppressing stickiness when applied to the skin, among non-volatile oils that are liquid at 25 ° C. It is more preferably one or more selected from the group consisting of ester oils and hydrocarbon oils, and even more preferably selected from the group consisting of alkyl benzoate (C12-15), isopropyl palmitate, and light liquid isoparaffin. It is one or more kinds.
 本発明の皮膚外用剤が成分(f1)を含有する場合、その含有量は、成分(a)~(c)を分散させ、及び他の配合成分を分散又は溶解させて皮膚への塗布性を向上させる観点、並びに水中油型、又は油中水型の皮膚外用剤を調製する観点から、好ましくは1質量%以上、より好ましくは4質量%以上、更に好ましくは8質量%以上である。また、優れた赤外線防御効果を得る観点、及び皮膚に塗布した際のべたつき抑制の観点から、好ましくは99質量%以下、より好ましくは90質量%以下、更に好ましくは80質量%以下、より更に好ましくは50質量%以下、より更に好ましくは30質量%以下である。皮膚外用剤中の成分(f1)の含有量の具体的範囲は、好ましくは1質量%以上99質量%以下、より好ましくは4質量%以上90質量%以下、更に好ましくは8質量%以上80質量%以下、より更に好ましくは8質量%以上50質量%以下、より更に好ましくは8質量%以上30質量%以下である。 When the external preparation for skin of the present invention contains the component (f1), the content thereof disperses the components (a) to (c) and disperses or dissolves other compounding components to improve the applicability to the skin. From the viewpoint of improving and preparing an oil-in-water type or water-in-oil type skin external preparation, it is preferably 1% by mass or more, more preferably 4% by mass or more, and further preferably 8% by mass or more. Further, from the viewpoint of obtaining an excellent infrared protection effect and suppressing stickiness when applied to the skin, it is preferably 99% by mass or less, more preferably 90% by mass or less, still more preferably 80% by mass or less, still more preferably. Is 50% by mass or less, more preferably 30% by mass or less. The specific range of the content of the component (f1) in the external preparation for skin is preferably 1% by mass or more and 99% by mass or less, more preferably 4% by mass or more and 90% by mass or less, and further preferably 8% by mass or more and 80% by mass. % Or less, more preferably 8% by mass or more and 50% by mass or less, still more preferably 8% by mass or more and 30% by mass or less.
 本発明の皮膚外用剤が成分(f1)を含有する場合、成分(a)~(c)の合計配合量と成分(f1)との質量比[{(a)+(b)+(c)}/(f1)]は、優れた赤外線防御効果を得る観点、及び、皮膚外用剤を皮膚に塗布した際に白くなりにくく、且つ自然な色合いを得る観点から、好ましくは0.01以上、より好ましくは0.05以上、更に好ましくは0.1以上であり、油溶性の紫外線吸収剤を溶解させる観点、塗布性向上の観点、並びに水中油型、又は油中水型の皮膚外用剤を調製する観点から、好ましくは10以下、より好ましくは5以下、更に好ましくは3以下、より更に好ましくは1以下、より更に好ましくは0.5以下である。質量比[{(a)+(b)+(c)}/(f1)]の具体的範囲は、好ましくは0.01以上10以下、より好ましくは0.01以上5以下、更に好ましくは0.05以上3以下、より更に好ましくは0.1以上1以下、より更に好ましくは0.3以上0.5以下である。 When the external preparation for skin of the present invention contains the component (f1), the mass ratio of the total amount of the components (a) to (c) to the component (f1) [{(a) + (b) + (c) } / (F1)] is preferably 0.01 or more, from the viewpoint of obtaining an excellent ultraviolet protection effect, and from the viewpoint of obtaining a natural color tone without becoming white when an external preparation for skin is applied to the skin. It is preferably 0.05 or more, more preferably 0.1 or more, and prepares an oil-in-water type or a water-in-oil type skin external preparation from the viewpoint of dissolving an oil-soluble ultraviolet absorber, improving coatability, and preparing. From this point of view, it is preferably 10 or less, more preferably 5 or less, still more preferably 3 or less, still more preferably 1 or less, still more preferably 0.5 or less. The specific range of the mass ratio [{(a) + (b) + (c)} / (f1)] is preferably 0.01 or more and 10 or less, more preferably 0.01 or more and 5 or less, and further preferably 0. It is 0.05 or more and 3 or less, more preferably 0.1 or more and 1 or less, and even more preferably 0.3 or more and 0.5 or less.
 また本発明の皮膚外用剤が成分(e)及び成分(f1)を含有する場合、質量比[(e)/(f1)]は、優れた紫外線防御効果を得る観点から、好ましくは0.01以上、より好ましくは0.02以上、更に好ましくは0.05以上、より更に好ましくは0.1以上であり、また、成分(e)として油溶性の紫外線吸収剤を用いた場合にはその溶解性の観点から、好ましくは10以下、より好ましくは5以下、更に好ましくは3以下である。質量比[(e)/(f1)]の具体的範囲は、好ましくは0.01以上10以下、より好ましくは0.02以上5以下、更に好ましくは0.05以上3以下、より更に好ましくは0.1以上3以下である。 When the external preparation for skin of the present invention contains the component (e) and the component (f1), the mass ratio [(e) / (f1)] is preferably 0.01 from the viewpoint of obtaining an excellent ultraviolet protection effect. The above is more preferably 0.02 or more, further preferably 0.05 or more, still more preferably 0.1 or more, and when an oil-soluble ultraviolet absorber is used as the component (e), its dissolution. From the viewpoint of sex, it is preferably 10 or less, more preferably 5 or less, still more preferably 3 or less. The specific range of the mass ratio [(e) / (f1)] is preferably 0.01 or more and 10 or less, more preferably 0.02 or more and 5 or less, still more preferably 0.05 or more and 3 or less, still more preferably. It is 0.1 or more and 3 or less.
(揮発性油(f2))
 本明細書において揮発性油とは、前述した紫外線吸収剤(e)以外の油剤であって、以下の方法(1)により測定される、25℃、6時間での蒸発量が20%以上のものをいう。
 方法(1):直径120mmのガラス製シャーレの中に、直径90mmの濾紙を入れ、濾紙にサンプルを1gのせて、65%RHの室内(25℃)に保存する。そして6時間後のサンプルの残留物を測定し、蒸発量を算出する。
(Volatile oil (f2))
In the present specification, the volatile oil is an oil agent other than the above-mentioned ultraviolet absorber (e), and the amount of evaporation at 25 ° C. for 6 hours measured by the following method (1) is 20% or more. Say something.
Method (1): A filter paper having a diameter of 90 mm is placed in a glass petri dish having a diameter of 120 mm, 1 g of a sample is placed on the filter paper, and the sample is stored in a room (25 ° C.) at 65% RH. Then, the residue of the sample after 6 hours is measured, and the amount of evaporation is calculated.
 成分(f2)は、好ましくは揮発性シリコーン油であり、より好ましくは直鎖状オルガノポリシロキサン及び環状オルガノポリシロキサンのうち、25℃で液状であり揮発性のものである。
 直鎖状オルガノポリシロキサンの具体例としては、オクタメチルトリシロキサン、デカメチルテトラシロキサン、ドデカメチルペンタシロキサン、1,1,1,3,5,5,5-ヘプタメチル-3-[(トリメチルシリル)オキシ]-トリシロキサンが挙げられる。
 環状オルガノポリシロキサンとしては、炭素数が1以上5以下のアルキル基を置換基として有する4~6員環の環状シロキサンが挙げられ、具体例として、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン等が挙げられる。
The component (f2) is preferably a volatile silicone oil, and more preferably a linear organopolysiloxane or a cyclic organopolysiloxane that is liquid and volatile at 25 ° C.
Specific examples of the linear organopolysiloxane include octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, 1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl) oxy. ] -Trisiloxane can be mentioned.
Examples of the cyclic organopolysiloxane include 4- to 6-membered cyclic siloxanes having an alkyl group having 1 or more and 5 or less carbon atoms as a substituent, and specific examples thereof include octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane. Can be mentioned.
 上記の中でも、成分(f2)としては皮膚に塗布した際のべたつき抑制の観点から環状オルガノポリシロキサンが好ましく、デカメチルシクロペンタシロキサンがより好ましい。 Among the above, as the component (f2), cyclic organopolysiloxane is preferable, and decamethylcyclopentasiloxane is more preferable, from the viewpoint of suppressing stickiness when applied to the skin.
 成分(f2)として用いることができる揮発性シリコーン油の市販品としては、信越化学工業(株)製の「KF-96A-1cs」(オクタメチルトリシロキサン)、「KF-96L-1.5cs」(デカメチルテトラシロキサン)、「KF-96L-2cs」(ドデカメチルペンタシロキサン)、「KF-995」(デカメチルシクロペンタシロキサン)、「TMF-1.5」(1,1,1,3,5,5,5-ヘプタメチル-3-[(トリメチルシリル)オキシ]-トリシロキサン)、ダウ・東レ(株)製の「DOWSIL SH200C Fluid 1cs」(オクタメチルトリシロキサン)、「DOWSIL SH200C Fluid 1.5cs」(デカメチルテトラシロキサン)、「DOWSIL SH200C Fluid 2cs」(ドデカメチルペンタシロキサン)、「DOWSIL SH245 Fluid」(デカメチルシクロペンタシロキサン)、モメンティブ・パフォーマンス・マテリアルズ社製の「TSF405」(デカメチルシクロペンタシロキサン)が挙げられる。 Commercially available volatile silicone oils that can be used as component (f2) include "KF-96A-1cs" (octamethyltrisiloxane) and "KF-96L-1.5cs" manufactured by Shin-Etsu Chemical Industry Co., Ltd. (Decamethyltetrasiloxane), "KF-96L-2cs" (Dodecamethylpentasiloxane), "KF-995" (Decamethylcyclopentasiloxane), "TMF-1.5" (1,1,1,3) 5,5,5-Heptamethyl-3-[(trimethylsilyl) oxy] -trisiloxane), "DOWNSIL SH200C Fluid 1cs" (octamethyltrisiloxane), "DOWNSIL SH200C Fluid 1.5cs" manufactured by Dow Toray Co., Ltd. (Decamethyltetrasiloxane), "DOWNSIL SH200C Fluid 2cs" (Dodecamethylpentasiloxane), "DOWNSIL SH245 Fluid" (Decamethylcyclopentasiloxane), "TSF405" (Decamethylcyclopenta) manufactured by Momentive Performance Materials. Siloxane).
 本発明の皮膚外用剤が成分(f2)を含有する場合、その含有量は、皮膚外用剤の剤型により適宜選択することができるが、好ましくは1質量%以上、より好ましくは5質量%以上、更に好ましくは10質量%以上とすることができる。また、皮膚に塗布した際のべたつき抑制の観点から、好ましくは85質量%以下、より好ましくは80質量%以下、更に好ましくは75質量%以下とすることができる。皮膚外用剤中の成分(f2)の含有量の具体的範囲は、好ましくは1質量%以上85質量%以下、より好ましくは5質量%以上80質量%以下、更に好ましくは10質量%以上75質量%以下である。 When the external preparation for skin of the present invention contains the component (f2), the content thereof can be appropriately selected depending on the dosage form of the external preparation for skin, but is preferably 1% by mass or more, more preferably 5% by mass or more. , More preferably, it can be 10% by mass or more. Further, from the viewpoint of suppressing stickiness when applied to the skin, it can be preferably 85% by mass or less, more preferably 80% by mass or less, and further preferably 75% by mass or less. The specific range of the content of the component (f2) in the external preparation for skin is preferably 1% by mass or more and 85% by mass or less, more preferably 5% by mass or more and 80% by mass or less, and further preferably 10% by mass or more and 75% by mass. % Or less.
(水性媒体)
 本発明の皮膚外用剤は、成分(a)~(c)及び他の配合成分を分散又は溶解させる観点、並びに水中油型、又は油中水型の皮膚外用剤を調製する観点から、必要に応じ、さらに水性媒体を含有することができる。当該水性媒体としては、成分(a)~(c)及び他の配合成分を分散又は溶解しうるものであれば特に制限されず、例えば、水;エタノール、イソプロピルアルコール、ブチルアルコール等の炭素数4以下の1価アルコール;1,3-ブチレングリコール、グリセリン、エチレングリコール、プロピレングリコール、ジエチレングリコール、ジプロピレングリコール等の炭素数6以下の低分子ジオール及びトリオールが挙げられる。これらの中でも、水及び炭素数4以下の1価アルコールからなる群から選ばれる1種以上が好ましく、水及びエタノールからなる群から選ばれる1種以上がより好ましい。
(Aqueous medium)
The external preparation for skin of the present invention is necessary from the viewpoint of dispersing or dissolving the components (a) to (c) and other compounding components, and from the viewpoint of preparing an oil-in-water type or a water-in-oil type skin external preparation. Depending on the situation, an aqueous medium can be further contained. The aqueous medium is not particularly limited as long as it can disperse or dissolve the components (a) to (c) and other compounding components, and is, for example, water; ethanol, isopropyl alcohol, butyl alcohol and the like having 4 carbon atoms. The following monohydric alcohols; low molecular weight diols having 6 or less carbon atoms such as 1,3-butylene glycol, glycerin, ethylene glycol, propylene glycol, diethylene glycol, and dipropylene glycol, and triol can be mentioned. Among these, one or more selected from the group consisting of water and a monohydric alcohol having 4 or less carbon atoms is preferable, and one or more selected from the group consisting of water and ethanol is more preferable.
 皮膚外用剤中の水性媒体を含有する場合、その含有量は、皮膚外用剤の剤型により適宜選択することができるが、好ましくは5質量%以上、より好ましくは8質量%以上、更に好ましくは10質量%以上とすることができる。また、好ましくは99質量%以下、より好ましくは90質量%以下、更に好ましくは70質量%以下、より更に好ましくは50質量%以下とすることができる。 When the aqueous medium in the external preparation for skin is contained, the content thereof can be appropriately selected depending on the dosage form of the external preparation for skin, but is preferably 5% by mass or more, more preferably 8% by mass or more, still more preferably. It can be 10% by mass or more. Further, it can be preferably 99% by mass or less, more preferably 90% by mass or less, still more preferably 70% by mass or less, still more preferably 50% by mass or less.
<その他の成分>
 本発明の皮膚外用剤は、上記成分以外に、必要に応じて他の成分、例えば、界面活性剤、紫外線散乱剤、制汗剤、香料、保湿剤、増粘剤、殺菌剤、pH調整剤、酸化防止剤、防腐剤等を含有させることもできる。
<Other ingredients>
In addition to the above components, the external preparation for skin of the present invention contains other components as required, such as surfactants, ultraviolet scattering agents, antiperspirants, fragrances, moisturizers, thickeners, bactericides, and pH adjusters. , Antioxidants, preservatives and the like can also be contained.
(皮膚外用剤の製造方法)
 本発明の皮膚外用剤の製造方法は特に限定されず、皮膚外用剤の剤型に応じて公知の方法を適宜用いることができる。例えば、成分(a)~(c)、及びその他の全成分を配合し、ホモジナイザー、ディスパー等により均一に混合する方法が挙げられる。水性媒体を配合する場合には、水性媒体以外の全成分を配合し、ディスパー等により均一に混合した後に、水性媒体を配合して更にホモジナイザー等により撹拌混合する方法も用いることができる。
(Manufacturing method of external preparation for skin)
The method for producing the external preparation for skin of the present invention is not particularly limited, and a known method can be appropriately used depending on the dosage form of the external preparation for skin. For example, a method of blending the components (a) to (c) and all other components and uniformly mixing them with a homogenizer, a disper, or the like can be mentioned. When blending an aqueous medium, it is also possible to use a method in which all the components other than the aqueous medium are blended, uniformly mixed with a disper or the like, then the aqueous medium is blended and further stirred and mixed with a homogenizer or the like.
[皮膚の赤外線防御方法]
 本発明はまた、本発明の皮膚外用剤を皮膚に塗布する、皮膚の赤外線防御方法を提供する。本発明の防御方法は、前記本発明の皮膚外用剤を皮膚に塗布する工程を有していれば特に制限されない。
[Infrared protection method for skin]
The present invention also provides a method for protecting against infrared rays of the skin by applying the external preparation for skin of the present invention to the skin. The protective method of the present invention is not particularly limited as long as it has a step of applying the external preparation for skin of the present invention to the skin.
 本発明の防御方法においては、波長1500nmの赤外線防御率が、好ましくは10%以上であり、より好ましくは12%以上であり、更に好ましくは15%以上である。波長1500nmの赤外線防御率が上記範囲であると、皮膚の遮熱実感が良好である。赤外線防御率(%)は、分光光度計で測定した赤外線透過率をX(%)とした場合に100-X(%)で表される値であり、具体的には実施例に記載の方法により測定できる。
 本発明の皮膚外用剤を皮膚に塗布することにより、赤外線を効果的に防御することができる。
In the protection method of the present invention, the infrared protection rate at a wavelength of 1500 nm is preferably 10% or more, more preferably 12% or more, still more preferably 15% or more. When the infrared protection rate at a wavelength of 1500 nm is in the above range, the actual feeling of heat insulation of the skin is good. The infrared protection rate (%) is a value represented by 100-X (%) when the infrared transmittance measured by a spectrophotometer is X (%), and specifically, the method described in Examples. Can be measured by.
By applying the external preparation for skin of the present invention to the skin, infrared rays can be effectively protected.
 上述の実施形態に関し、本発明はさらに以下の実施態様を開示する。
<1>
 下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状金属酸化物、
(b)厚さ125nm以上145nm以下の板状金属酸化物、及び
(c)厚さ180nm以上200nm以下の板状金属酸化物、
を配合してなり、
 該成分(a)~(c)の合計配合量100質量%に対し、成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、成分(c)の配合量が5質量%以上70質量%以下である、皮膚外用剤。
<2>
 前記板状金属酸化物が好ましくは板状酸化チタン及び板状酸化亜鉛からなる群から選ばれる1種以上であり、より好ましくは板状酸化チタンである、<1>の皮膚外用剤。
<3>
 前記板状金属酸化物が、好ましくはシリコーン及びアルキルアルコキシシランからなる群から選ばれる1種以上、より好ましくはメチルポリシロキサン、ジメチルポリシロキサン、メチルハイドロジェンポリシロキサン、(アクリル酸アルキル/ジメチコン)コポリマー、及びオクチルトリエトキシシランからなる群から選ばれる1種以上により表面処理されたものである、<1>又は<2>の皮膚外用剤。
<4>
 成分(a)の厚さが、好ましくは105nm以上、115nm以下であり、成分(b)の厚さが、好ましくは130nm以上、140nm以下であり、成分(c)の厚さが、好ましくは185nm以上、195nm以下である、<1>~<3>のいずれか1の皮膚外用剤。
<5>
 成分(a)~(c)の平均粒径が、好ましくは1μm以上20μm以下、より好ましくは2μm以上15μm以下、更に好ましくは2μm以上12μm以下、より更に好ましくは3μm以上10μm以下、より更に好ましくは5μm以上10μm以下である、<1>~<4>のいずれか1の皮膚外用剤。
<6>
 成分(a)~(c)のアスペクト比が、好ましくは10以上200以下、より好ましくは10以上150以下、更に好ましくは10以上100以下、より更に好ましくは20以上100以下、より更に好ましくは30以上100以下、より更に好ましくは35以上90以下である、<1>~<5>のいずれか1の皮膚外用剤。
<7>
 成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の配合割合が以下の条件1を満たし、好ましくは更に、以下の条件2を満たす、<1>~<6>のいずれか1の皮膚外用剤。
 条件1:成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の質量%を示した三相図において、各成分の配合割合が、下記で示した6組成点で囲まれた組成領域の範囲内である。
 (a,b,c)=(70,15,15)、(28,26,46)、(5,40,55)、(5,67,28)、(20,68,12)、(57,33,10)
 条件2:成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の質量%を示した三相図において、各成分の配合割合が、下記で示した6組成点で囲まれた組成領域の範囲内である。
 (a,b,c)=(50,28,22)、(25,45,30)、(25,32,43)、(15,43,42)、(23,55,22)、(42,43,15)
<8>
 皮膚外用剤における成分(a)~(c)の合計配合量が、好ましくは1質量%以上35質量%以下、より好ましくは1質量%以上25質量%以下、更に好ましくは1質量%以上20質量%以下、より更に好ましくは1質量%以上15質量%以下、より更に好ましくは1.5質量%以上10質量%以下、より更に好ましくは2質量%以上10質量%以下である、<1>~<7>のいずれか1の皮膚外用剤。
With respect to the above embodiments, the present invention further discloses the following embodiments.
<1>
The following components (a) to (c):
(A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less,
(B) Plate-shaped metal oxides with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped metal oxides with a thickness of 180 nm or more and 200 nm or less.
It is made by blending
The blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass with respect to the total blending amount of the components (a) to (c) of 100% by mass. % Or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less, which is an external preparation for skin.
<2>
The skin external preparation of <1>, wherein the plate-shaped metal oxide is preferably one or more selected from the group consisting of plate-shaped titanium oxide and plate-shaped zinc oxide, and more preferably plate-shaped titanium oxide.
<3>
The plate-like metal oxide is preferably one or more selected from the group consisting of silicone and alkylalkoxysilane, more preferably methylpolysiloxane, dimethylpolysiloxane, methylhydrogenpolysiloxane, (alkyl acrylate / dimethicone) copolymer. The external preparation for skin of <1> or <2>, which is surface-treated with one or more selected from the group consisting of octyltriethoxysilane and.
<4>
The thickness of the component (a) is preferably 105 nm or more and 115 nm or less, the thickness of the component (b) is preferably 130 nm or more and 140 nm or less, and the thickness of the component (c) is preferably 185 nm. The external preparation for skin according to any one of <1> to <3>, which is 195 nm or less.
<5>
The average particle size of the components (a) to (c) is preferably 1 μm or more and 20 μm or less, more preferably 2 μm or more and 15 μm or less, still more preferably 2 μm or more and 12 μm or less, still more preferably 3 μm or more and 10 μm or less, still more preferably. An external preparation for skin according to any one of <1> to <4>, which is 5 μm or more and 10 μm or less.
<6>
The aspect ratios of the components (a) to (c) are preferably 10 or more and 200 or less, more preferably 10 or more and 150 or less, still more preferably 10 or more and 100 or less, still more preferably 20 or more and 100 or less, still more preferably 30. The external preparation for skin according to any one of <1> to <5>, which is 100 or more, more preferably 35 or more and 90 or less.
<7>
The compounding ratio of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total compounding amount of the components (a) to (c) satisfies the following condition 1, and preferably the following condition 2 is further satisfied. The external preparation for skin according to any one of <1> to <6>.
Condition 1: In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
(A, b, c) = (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12), (57 , 33, 10)
Condition 2: In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
(A, b, c) = (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22), (42) , 43, 15)
<8>
The total amount of the components (a) to (c) in the external preparation for skin is preferably 1% by mass or more and 35% by mass or less, more preferably 1% by mass or more and 25% by mass or less, and further preferably 1% by mass or more and 20% by mass. % Or less, more preferably 1% by mass or more and 15% by mass or less, still more preferably 1.5% by mass or more and 10% by mass or less, still more preferably 2% by mass or more and 10% by mass or less, <1> to An external preparation for skin according to any one of <7>.
<9>
 さらに成分(d)として感触向上剤を含有する、<1>~<8>のいずれか1の皮膚外用剤。
<10>
 成分(d)が、好ましくは球状無機粒子であり、より好ましくは球状金属酸化物粒子であり、更に好ましくは球状酸化チタン粒子及び球状酸化亜鉛粒子からなる群から選ばれる1種以上であり、より更に好ましくは球状酸化チタン粒子である、<9>の皮膚外用剤。
<11>
 成分(d)として用いられる粒子の平均粒径が、好ましくは0.1μm以上10μm以下、より好ましくは0.2μm以上5μm以下、更に好ましくは0.5μm以上2μm以下である、<9>又は<10>の皮膚外用剤。
<12>
 成分(d)の含有量が、好ましくは1質量%以上20質量%以下、より好ましくは1質量%以上15質量%以下、更に好ましくは1質量%以上10質量%以下、より更に好ましくは1.5質量%以上10質量%以下、より更に好ましくは2質量%以上10質量%以下である、<9>~<11>のいずれか1の皮膚外用剤。
<13>
 成分(a)~(c)の合計配合量と成分(d)との質量比[{(a)+(b)+(c)}/(d)]が、好ましくは0.1以上5以下、より好ましくは0.2以上3以下、更に好ましくは0.5以上2以下、より更に好ましくは0.5以上1.5以下である、<9>~<12>のいずれか1の皮膚外用剤。
<14>
 さらに成分(e)として紫外線吸収剤を含有する、<1>~<13>のいずれか1の皮膚外用剤。
<15>
 成分(e)が好ましくは油溶性の有機紫外線吸収剤であり、より好ましくはパラメトキシケイ皮酸2-エチルヘキシル、4-tert-ブチル-4’-メトキシジベンゾイルメタン、オクトクリレン、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2-エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール、及び2,4,6-トリス[4-(2-エチルへキシルオキシカルボニル)アニリノ]-1,3,5-トリアジンからなる群から選ばれる1種以上が好ましく、パラメトキシケイ皮酸2-エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、及び2,4,6-トリス[4-(2-エチルへキシルオキシカルボニル)アニリノ]-1,3,5-トリアジンからなる群から選ばれる1種以上、更に好ましくは、パラメトキシケイ皮酸2-エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、及びビスエチルヘキシルオキシフェノールメトキシフェニルトリアジンからなる群から選ばれる1種以上である、<14>の皮膚外用剤。
<16>
 成分(e)の含有量が、好ましくは0.2質量%以上30質量%以下、より好ましくは1質量%以上25質量%以下、更に好ましくは3質量%以上20質量%以下、より更に好ましくは5質量%以上15質量%以下である、<14>又は<15>の皮膚外用剤。
<17>
 成分(a)~(c)の合計配合量と成分(e)との質量比[{(a)+(b)+(c)}/(e)]が、好ましくは0.1以上5以下、より好ましくは0.1以上3以下、更に好ましくは0.2以上1以下、より更に好ましくは0.3以上1以下、より更に好ましくは0.3以上0.5以下である、<14>~<16>のいずれか1の皮膚外用剤。
<18>
 さらに成分(f)として油剤を含有し、好ましくは不揮発性油(f1)を含む、<1>~<17>のいずれか1の皮膚外用剤。
<19>
 成分(f1)が、エステル油、シリコーン油、炭化水素油、高級脂肪酸、及び高級アルコールからなる群から選ばれる1種以上、より好ましくはエステル油、シリコーン油及び炭化水素油からなる群から選ばれる1種以上、更に好ましくはエステル油及び炭化水素油からなる群から選ばれる1種以上、より更に好ましくは安息香酸アルキル(C12~15)、パルミチン酸イソプロピル、及び軽質流動イソパラフィンからなる群から選ばれる1種以上である、<18>の皮膚外用剤。
<20>
 成分(f1)の含有量が、好ましくは1質量%以上99質量%以下、より好ましくは4質量%以上90質量%以下、更に好ましくは8質量%以上80質量%以下、より更に好ましくは8質量%以上50質量%以下、より更に好ましくは8質量%以上30質量%以下である、<18>又は<19>の皮膚外用剤。
<21>
 成分(a)~(c)の合計配合量と成分(f1)との質量比[{(a)+(b)+(c)}/(f1)]が、好ましくは0.01以上10以下、より好ましくは0.01以上5以下、更に好ましくは0.05以上3以下、より更に好ましくは0.1以上1以下、より更に好ましくは0.3以上0.5以下である、<18>~<20>のいずれか1の皮膚外用剤。
<22>
 質量比[(e)/(f1)]が、好ましくは0.01以上10以下、より好ましくは0.02以上5以下、更に好ましくは0.05以上3以下、より更に好ましくは0.1以上3以下である、<18>~<21>のいずれか1の皮膚外用剤。
<23>
 成分(f)として揮発性油(f2)、好ましくは揮発性シリコーン油、より好ましくは直鎖状オルガノポリシロキサン及び環状オルガノポリシロキサンのうち25℃で液状であり揮発性のもの、更に好ましくは環状オルガノポリシロキサン、より更に好ましくは炭素数が1以上5以下のアルキル基を置換基として有する4~6員環の環状シロキサン、より更に好ましくはデカメチルシクロペンタシロキサンを含有する、<18>~<22>のいずれか1の皮膚外用剤。
<24>
 成分(f2)の含有量が、好ましくは1質量%以上85質量%以下、より好ましくは5質量%以上80質量%以下、更に好ましくは10質量%以上75質量%以下である、<23>の皮膚外用剤。
<9>
The external preparation for skin according to any one of <1> to <8>, which further contains a feel-improving agent as the component (d).
<10>
The component (d) is preferably spherical inorganic particles, more preferably spherical metal oxide particles, and further preferably one or more selected from the group consisting of spherical titanium oxide particles and spherical zinc oxide particles. More preferably, the external preparation for skin of <9>, which is spherical titanium oxide particles.
<11>
The average particle size of the particles used as the component (d) is preferably 0.1 μm or more and 10 μm or less, more preferably 0.2 μm or more and 5 μm or less, and further preferably 0.5 μm or more and 2 μm or less, <9> or <. 10> External skin preparation.
<12>
The content of the component (d) is preferably 1% by mass or more and 20% by mass or less, more preferably 1% by mass or more and 15% by mass or less, still more preferably 1% by mass or more and 10% by mass or less, still more preferably 1. The external preparation for skin according to any one of <9> to <11>, which is 5% by mass or more and 10% by mass or less, more preferably 2% by mass or more and 10% by mass or less.
<13>
The mass ratio of the total amount of the components (a) to (c) to the component (d) [{(a) + (b) + (c)} / (d)] is preferably 0.1 or more and 5 or less. , More preferably 0.2 or more and 3 or less, still more preferably 0.5 or more and 2 or less, still more preferably 0.5 or more and 1.5 or less, for external use of any one of <9> to <12>. Agent.
<14>
The external preparation for skin according to any one of <1> to <13>, which further contains an ultraviolet absorber as a component (e).
<15>
Ingredient (e) is preferably an oil-soluble organic ultraviolet absorber, more preferably 2-ethylhexyl paramethoxysilicate, 4-tert-butyl-4'-methoxydibenzoylmethane, octocrylene, dimethoxybenzylene dioxoimidazo. 2-Ethylhexyl lysinepropionate, hexyl diethylaminohydroxybenzoylbenzoate, bisethylhexyloxyphenol methoxyphenyltriazine, methylenebisbenzotriazolyltetramethylbutylphenol, and 2,4,6-tris [4- (2-ethylhexyloxy) One or more selected from the group consisting of carbonyl) anilino] -1,3,5-triazine, preferably 2-ethylhexyl paramethoxysilicate, hexyl diethylaminohydroxybenzoylbenzoate, bisethylhexyloxyphenol methoxyphenyltriazine, and 2 , 4,6-Tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, one or more selected from the group, more preferably 2-ethylhexyl paramethoxysilicate. The skin external preparation of <14>, which is one or more selected from the group consisting of hexyl diethylaminohydroxybenzoylbenzoate, and bisethylhexyloxyphenol methoxyphenyltriazine.
<16>
The content of the component (e) is preferably 0.2% by mass or more and 30% by mass or less, more preferably 1% by mass or more and 25% by mass or less, still more preferably 3% by mass or more and 20% by mass or less, still more preferably. <14> or <15> external preparation for skin, which is 5% by mass or more and 15% by mass or less.
<17>
The mass ratio of the total amount of the components (a) to (c) to the component (e) [{(a) + (b) + (c)} / (e)] is preferably 0.1 or more and 5 or less. , More preferably 0.1 or more and 3 or less, still more preferably 0.2 or more and 1 or less, still more preferably 0.3 or more and 1 or less, still more preferably 0.3 or more and 0.5 or less, <14>. An external preparation for skin according to any one of ~ <16>.
<18>
The external preparation for skin according to any one of <1> to <17>, which further contains an oil agent as a component (f) and preferably contains a non-volatile oil (f1).
<19>
The component (f1) is selected from one or more selected from the group consisting of ester oils, silicone oils, hydrocarbon oils, higher fatty acids, and higher alcohols, and more preferably selected from the group consisting of ester oils, silicone oils, and hydrocarbon oils. One or more, more preferably one or more selected from the group consisting of ester oils and hydrocarbon oils, even more preferably selected from the group consisting of alkyl benzoate (C12-15), isopropyl palmitate, and light liquid isoparaffin. <18> external skin preparation, which is one or more.
<20>
The content of the component (f1) is preferably 1% by mass or more and 99% by mass or less, more preferably 4% by mass or more and 90% by mass or less, still more preferably 8% by mass or more and 80% by mass or less, still more preferably 8% by mass. % Or more and 50% by mass or less, more preferably 8% by mass or more and 30% by mass or less, <18> or <19> for external use on the skin.
<21>
The mass ratio of the total amount of the components (a) to (c) to the component (f1) [{(a) + (b) + (c)} / (f1)] is preferably 0.01 or more and 10 or less. , More preferably 0.01 or more and 5 or less, still more preferably 0.05 or more and 3 or less, still more preferably 0.1 or more and 1 or less, still more preferably 0.3 or more and 0.5 or less, <18>. An external preparation for skin according to any one of ~ <20>.
<22>
The mass ratio [(e) / (f1)] is preferably 0.01 or more and 10 or less, more preferably 0.02 or more and 5 or less, still more preferably 0.05 or more and 3 or less, still more preferably 0.1 or more. An external preparation for skin according to any one of <18> to <21>, which is 3 or less.
<23>
Volatile oil (f2) as the component (f), preferably volatile silicone oil, more preferably linear organopolysiloxane and cyclic organopolysiloxane, which are liquid and volatile at 25 ° C., more preferably cyclic. <18> to <containing an organopolysiloxane, more preferably a 4- to 6-membered cyclic siloxane having an alkyl group having 1 or more and 5 or less carbon atoms as a substituent, and even more preferably a decamethylcyclopentasiloxane. 22> Any one of the external preparations for skin.
<24>
The content of the component (f2) is preferably 1% by mass or more and 85% by mass or less, more preferably 5% by mass or more and 80% by mass or less, and further preferably 10% by mass or more and 75% by mass or less, <23>. External preparation for skin.
<25>
 皮膚外用剤であって、下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状酸化チタン、
(b)厚さ125nm以上145nm以下の板状酸化チタン、及び
(c)厚さ180nm以上200nm以下の板状酸化チタン、
を配合してなり、
 該成分(a)~(c)の平均粒径が3μm以上10μm以下であり、
 該成分(a)~(c)の合計配合量100質量%に対し、成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、成分(c)の配合量が5質量%以上70質量%以下であり、
 前記皮膚外用剤における成分(a)~(c)の合計配合量が2質量%以上10質量%以下である、皮膚外用剤。
<26>
 皮膚外用剤であって、下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状酸化チタン、
(b)厚さ125nm以上145nm以下の板状酸化チタン、及び
(c)厚さ180nm以上200nm以下の板状酸化チタン、
を配合してなり、
 該成分(a)~(c)の平均粒径が3μm以上10μm以下であり、
 成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の配合割合が以下の条件1を満たし、
 前記皮膚外用剤における成分(a)~(c)の合計配合量が2質量%以上10質量%以下である、皮膚外用剤。
 条件1:成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の質量%を示した三相図において、各成分の配合割合が、下記で示した6組成点で囲まれた組成領域の範囲内である。
 (a,b,c)=(70,15,15)、(28,26,46)、(5,40,55)、(5,67,28)、(20,68,12)、(57,33,10)
<27>
 皮膚外用剤であって、下記成分(a)~(c):
(a)厚さ100nm以上120nm以下の板状酸化チタン、
(b)厚さ125nm以上145nm以下の板状酸化チタン、及び
(c)厚さ180nm以上200nm以下の板状酸化チタン、
を配合してなり、
 該成分(a)~(c)の平均粒径が3μm以上10μm以下であり、
 成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の配合割合が以下の条件2を満たし、
 前記皮膚外用剤における成分(a)~(c)の合計配合量が2質量%以上10質量%以下である、皮膚外用剤。
 条件2:成分(a)~(c)の合計配合量100質量%に対する成分(a)、成分(b)及び成分(c)の質量%を示した三相図において、各成分の配合割合が、下記で示した6組成点で囲まれた組成領域の範囲内である。
 (a,b,c)=(50,28,22)、(25,45,30)、(25,32,43)、(15,43,42)、(23,55,22)、(42,43,15)
<28>
 さらに、成分(d)として球状酸化チタン粒子及び球状酸化亜鉛粒子からなる群から選ばれる1種以上の感触向上剤を2質量%以上10質量%以下含有し、
 成分(e)として油溶性の有機紫外線吸収剤を5質量%以上15質量%以下含有し、
 成分(f)としてエステル油及び炭化水素油からなる群から選ばれる1種以上の不揮発性油(f1)を8質量%以上50質量%以下含有する、<25>~<27>のいずれか1の皮膚外用剤。
<29>
 剤型が、液状、ゲル状、又はクリーム状である、<1>~<28>のいずれか1の皮膚外用剤。
<30>
 皮膚化粧料であり、好ましくは日焼け止め化粧料、サンタン、又は化粧下地化粧料である、<1>~<29>のいずれか1の皮膚外用剤。
<31>
 上記<1>~<30>のいずれか1の皮膚外用剤を皮膚に塗布する皮膚の赤外線防御方法。
<32>
 波長1500nmの赤外線防御率が、好ましくは10%以上であり、より好ましくは12%以上であり、更に好ましくは15%以上である、<31>の方法。
<25>
An external preparation for skin, the following components (a) to (c):
(A) Plate-shaped titanium oxide with a thickness of 100 nm or more and 120 nm or less,
(B) Plate-shaped titanium oxide with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped titanium oxide with a thickness of 180 nm or more and 200 nm or less.
It is made by blending
The average particle size of the components (a) to (c) is 3 μm or more and 10 μm or less.
The blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass with respect to the total blending amount of the components (a) to (c) of 100% by mass. % Or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less.
An external preparation for skin, wherein the total amount of the components (a) to (c) in the external preparation for skin is 2% by mass or more and 10% by mass or less.
<26>
An external preparation for skin, the following components (a) to (c):
(A) Plate-shaped titanium oxide with a thickness of 100 nm or more and 120 nm or less,
(B) Plate-shaped titanium oxide with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped titanium oxide with a thickness of 180 nm or more and 200 nm or less.
It is made by blending
The average particle size of the components (a) to (c) is 3 μm or more and 10 μm or less.
The compounding ratio of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total compounding amount of the components (a) to (c) satisfies the following condition 1.
An external preparation for skin, wherein the total amount of the components (a) to (c) in the external preparation for skin is 2% by mass or more and 10% by mass or less.
Condition 1: In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
(A, b, c) = (70,15,15), (28,26,46), (5,40,55), (5,67,28), (20,68,12), (57 , 33, 10)
<27>
An external preparation for skin, the following components (a) to (c):
(A) Plate-shaped titanium oxide with a thickness of 100 nm or more and 120 nm or less,
(B) Plate-shaped titanium oxide with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped titanium oxide with a thickness of 180 nm or more and 200 nm or less.
It is made by blending
The average particle size of the components (a) to (c) is 3 μm or more and 10 μm or less.
The compounding ratio of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total compounding amount of the components (a) to (c) satisfies the following condition 2.
An external preparation for skin, wherein the total amount of the components (a) to (c) in the external preparation for skin is 2% by mass or more and 10% by mass or less.
Condition 2: In a three-phase diagram showing the mass% of the component (a), the component (b) and the component (c) with respect to 100% by mass of the total blending amount of the components (a) to (c), the blending ratio of each component is , It is within the range of the composition region surrounded by the 6 composition points shown below.
(A, b, c) = (50,28,22), (25,45,30), (25,32,43), (15,43,42), (23,55,22), (42) , 43, 15)
<28>
Further, as the component (d), one or more kinds of feel improvers selected from the group consisting of spherical titanium oxide particles and spherical zinc oxide particles are contained in an amount of 2% by mass or more and 10% by mass or less.
It contains 5% by mass or more and 15% by mass or less of an oil-soluble organic ultraviolet absorber as the component (e).
Any one of <25> to <27> containing 8% by mass or more and 50% by mass or less of one or more non-volatile oils (f1) selected from the group consisting of ester oils and hydrocarbon oils as the component (f). Skin external preparation.
<29>
The external preparation for skin according to any one of <1> to <28>, wherein the dosage form is liquid, gel-like, or cream-like.
<30>
An external preparation for the skin according to any one of <1> to <29>, which is a skin cosmetic, preferably a sunscreen cosmetic, a suntan, or a makeup base cosmetic.
<31>
A method for protecting the skin from infrared rays by applying the external preparation for skin according to any one of <1> to <30> to the skin.
<32>
The method of <31>, wherein the infrared protection rate at a wavelength of 1500 nm is preferably 10% or more, more preferably 12% or more, still more preferably 15% or more.
 以下、本発明を実施例により説明するが、本発明は実施例の範囲に限定されない。なお本実施例において、各種測定及び評価は以下の方法により行った。 Hereinafter, the present invention will be described with reference to Examples, but the present invention is not limited to the scope of the Examples. In this example, various measurements and evaluations were carried out by the following methods.
(厚さの測定)
 成分(a)~(c)として用いた板状酸化チタンの厚さは、成分(a)~(c)を走査型電子顕微鏡((株)キーエンス製「VE-9800」)を用いて、加速電圧:10keV、観察倍率:10,000倍の条件で観察し、観察画像中の50個の粒子の厚さを測定して、個数あたりの平均値を算出することにより求めた。
(Measurement of thickness)
The thickness of the plate-shaped titanium oxide used as the components (a) to (c) is accelerated by accelerating the components (a) to (c) using a scanning electron microscope (“VE-9800” manufactured by KEYENCE CORPORATION). It was obtained by observing under the conditions of voltage: 10 keV and observation magnification: 10,000 times, measuring the thickness of 50 particles in the observed image, and calculating the average value per number.
(平均粒径、アスペクト比の測定)
 成分(a)~(c)として用いた板状酸化チタン、及び成分(d)として用いた球状酸化チタンの平均粒径は、レーザー回折/散乱式粒度分布測定装置((株)堀場製作所製「LA920」)を用いて、水分散液にて相対屈折率2.0、粒子径基準体積にて測定されたメディアン径(D50)の値を平均粒径とした。
 成分(a)~(c)として用いた板状酸化チタンのアスペクト比は、(平均粒径/厚さ)により算出した。
(Measurement of average particle size and aspect ratio)
The average particle size of the plate-shaped titanium oxide used as the components (a) to (c) and the spherical titanium oxide used as the component (d) is determined by a laser diffraction / scattering type particle size distribution measuring device (Horiba Seisakusho Co., Ltd.). Using LA920 ”), the average particle size was defined as the value of the median diameter (D50) measured with an aqueous dispersion having a relative refractive index of 2.0 and a particle size reference volume.
The aspect ratio of the plate-shaped titanium oxide used as the components (a) to (c) was calculated by (average particle size / thickness).
[評価(1):赤外線防御率、皮膚に塗布した際の色合い、及び総合評価]
(赤外線防御率)
 各例の皮膚外用剤28.5mgを5cm×5cmのポリメタクリル酸メチル樹脂(PMMA)基板(HelioScreen社製「HD6」)に塗布し、15分間乾燥させて測定用の試料とした。また、同様にグリセリンをPMMA基板に塗布し、15分乾燥させたものを対照用の試料とした。測定用試料、対照用試料それぞれについて、分光光度計((株)島津製作所製「UV-3600」)にて、積分球モードで、波長1500nmの透過率を測定した。測定用試料の透過率を対照用試料の透過率で除した値を透過率X(%)とし、100-X(%)を赤外線防御率とした。この値が大きいほど、赤外線防御効果が高いことを意味する。
[Evaluation (1): Infrared protection rate, color tone when applied to the skin, and comprehensive evaluation]
(Infrared protection rate)
28.5 mg of the external preparation for skin of each example was applied to a 5 cm × 5 cm polymethyl methacrylate resin (PMMA) substrate (“HD6” manufactured by HelioScreen) and dried for 15 minutes to prepare a sample for measurement. Similarly, glycerin was applied to the PMMA substrate and dried for 15 minutes, which was used as a control sample. For each of the measurement sample and the control sample, the transmittance at a wavelength of 1500 nm was measured in the integrating sphere mode with a spectrophotometer (“UV-3600” manufactured by Shimadzu Corporation). The value obtained by dividing the transmittance of the measurement sample by the transmittance of the control sample was defined as the transmittance X (%), and 100-X (%) was defined as the infrared protection rate. The larger this value is, the higher the infrared protection effect is.
(皮膚に塗布した際の色合い)
 各例の皮膚外用剤を、被験者4名の前腕2箇所に2mg/cm塗布した直後の色合いについて、非常に悪い場合を1点、非常に良い場合を5点として、下記評価基準により、0.5点刻みで10段階で評価した。専門パネラー2名で評価を行い、その平均点(小数第二位を四捨五入)を評価スコアとした。
<評価基準>
1:非常に悪い
2:悪い
3:どちらでもない
4:良い
5:非常に良い
(Tint when applied to the skin)
Regarding the color tone immediately after applying 2 mg / cm 2 of the external preparation for skin of each example to 2 places on the forearms of 4 subjects, 1 point was given for a very bad case and 5 points for a very good case, and 0 according to the following evaluation criteria. It was evaluated on a scale of 10 in 5 point increments. Evaluation was performed by two specialized panelists, and the average score (rounded to the first decimal place) was used as the evaluation score.
<Evaluation criteria>
1: Very bad 2: Bad 3: Neither 4: Good 5: Very good
(総合評価)
 表1に示す評価結果において、皮膚に塗布した際の色合いの評価スコアが3.6以上であるものをAランク、3.0以上3.5以下であるものをBランク、2.5以上2.9以下であるものをCランク、2.4以下であるものをDランクとした。更に、赤外線防御率が15%以上であるものについては1ランク上げ、15%未満であるものについては1ランク下げた結果を総合評価として表1に示した。総合評価はA+、A、B、C、D及びD-の6段階評価とした。
(Comprehensive evaluation)
In the evaluation results shown in Table 1, those with an evaluation score of 3.6 or more when applied to the skin are ranked A, those with a score of 3.0 or more and 3.5 or less are ranked B, and those with an evaluation score of 2.5 or more 2 Those having a value of 9.9 or less were given a C rank, and those having a value of 2.4 or less were given a D rank. Furthermore, Table 1 shows the results of one rank up for those with an infrared protection rate of 15% or more and one rank for those with an infrared protection rate of less than 15% as a comprehensive evaluation. The overall evaluation was a 6-grade evaluation of A +, A, B, C, D and D-.
[評価(2):色味及び透明感]
 各例の皮膚外用剤を皮膚に塗布した際に色味が赤、青、又は緑に偏っている、及び、透明感がなく白っぽい状態である等の見た目の不自然さを感じず、自然な色合いを実現しているかどうかを下記方法により評価した。
 肌色の異なる前腕4部位それぞれに皮膚外用剤を2mg/cm塗布した際の色味及び透明感を目視観察し、下記評価基準により、0.5点刻みで10段階で評価した。専門パネラー2名で評価を行い、その平均点(小数第二位を四捨五入)を評価スコアとした。
 赤味、青味、緑味、及び透明感の4項目について、評価スコア2.0未満の項目がなく、且つ評価スコア3.0以上の項目が2つ以上ある場合を合格、それ以外を不合格とした。
<評価基準>
(赤味)
5:赤味が少ない
4:赤味がやや少ない
3:どちらでもない
2:赤味がやや強い
1:赤味が強い
(青味)
5:青味が少ない
4:青味がやや少ない
3:どちらでもない
2:青味がやや強い
1:青味が強い
(緑味)
5:緑味が少ない
4:緑味がやや少ない
3:どちらでもない
2:緑味がやや強い
1:緑味が強い
(透明感)
5:透明感がある
4:やや透明感がある
3:どちらでもない
2:やや透明感がない
1:透明感がない
[Evaluation (2): Color and transparency]
When the external preparation for skin of each example is applied to the skin, the color is biased toward red, blue, or green, and there is no sense of transparency and the appearance is whitish, which is natural. Whether or not the hue was realized was evaluated by the following method.
The color and transparency when 2 mg / cm 2 of an external preparation for skin was applied to each of the four parts of the forearm having different skin colors were visually observed and evaluated on a scale of 10 in 0.5 point increments according to the following evaluation criteria. Evaluation was performed by two specialized panelists, and the average score (rounded to the first decimal place) was used as the evaluation score.
For the four items of redness, blueness, greenness, and transparency, pass if there are no items with an evaluation score of less than 2.0 and there are two or more items with an evaluation score of 3.0 or more, and the others are not accepted. It was passed.
<Evaluation criteria>
(Reddish)
5: Less redness 4: Slightly less redness 3: Neither 2: Slightly reddish 1: Strong redness (blue)
5: Less bluish 4: Slightly less bluish 3: Neither 2: Slightly bluish 1: Strong bluish (greenish)
5: Less green 4: Slightly less green 3: Neither 2: Slightly green 1: Strong green (transparency)
5: There is a sense of transparency 4: There is a sense of transparency 3: Neither 2: There is a sense of transparency 1: There is no sense of transparency
製造例1(板状酸化チタン1の製造)
 未処理の板状酸化チタン(CQV社製「Featheleve PT-7401K」、厚さ112nm、アスペクト比126、平均粒径14.1μm)を衝撃型分級機内蔵微粉砕機(ホソカワミクロン(株)製「ACM-10」)を用いて粉砕処理した後、(アクリル酸アルキル/ジメチコン)コポリマーにより被覆処理を行い、厚さ112nm、アスペクト比80、平均粒径9.0μmの板状酸化チタン1を得た。
Production Example 1 (Production of plate-shaped titanium oxide 1)
Untreated plate-shaped titanium oxide (CQV "Featheleve PT-7401K", thickness 112 nm, aspect ratio 126, average particle size 14.1 μm) is pulverized with a built-in impact classifier (ACM manufactured by Hosokawa Micron Co., Ltd.) After the pulverization treatment using -10 ”), a coating treatment was carried out with a (alkyl acrylate / dimethicone) copolymer to obtain a plate-shaped titanium oxide 1 having a thickness of 112 nm, an aspect ratio of 80 and an average particle size of 9.0 μm.
製造例2(板状酸化チタン2の製造)
 未処理の板状酸化チタンとして、CQV社製「Featheleve PT-7401K」に替えて、CQV社製「Featheleve PT-7801K」(厚さ134nm、アスペクト比95、平均粒径12.8μm)を使用したこと以外は、製造例1と同様に処理を行い、厚さ134nm、アスペクト比64、平均粒径8.6μmの板状酸化チタン2を得た。
Production Example 2 (Production of plate-shaped titanium oxide 2)
As the untreated plate-shaped titanium oxide, "Featheleve PT-7801K" (thickness 134 nm, aspect ratio 95, average particle size 12.8 μm) manufactured by CQV was used instead of "Feathereve PT-7401K" manufactured by CQV. Except for this, the same treatment as in Production Example 1 was carried out to obtain plate-shaped titanium oxide 2 having a thickness of 134 nm, an aspect ratio of 64, and an average particle size of 8.6 μm.
製造例3(板状酸化チタン3の製造)
 未処理の板状酸化チタンとして、CQV社製「Featheleve PT-7401K」に替えて、CQV社製「Featheleve PT-7901K」(厚さ191nm、アスペクト比58、平均粒径11.1μm)を使用したこと以外は、製造例1と同様に処理を行い、厚さ191nm、アスペクト比44、平均粒径8.5μmの板状酸化チタン3を得た。
Production Example 3 (Production of plate-shaped titanium oxide 3)
As the untreated plate-shaped titanium oxide, "Featheleve PT-7901K" (thickness 191 nm, aspect ratio 58, average particle size 11.1 μm) manufactured by CQV was used instead of "Featheleve PT-7401K" manufactured by CQV. Except for this, the same treatment as in Production Example 1 was carried out to obtain plate-shaped titanium oxide 3 having a thickness of 191 nm, an aspect ratio of 44, and an average particle size of 8.5 μm.
実施例1~12、比較例1~8(皮膚外用剤の製造及び評価)
 表1に示す成分を配合し、ホモジナイザーを用いて均一に混合し、表1に示す組成の皮膚外用剤を製造した。得られた皮膚外用剤について、前記方法で評価を実施した。結果を表1に示す。なお、表1に記載した配合量は各成分の有効成分量(質量%)である。
Examples 1 to 12 and Comparative Examples 1 to 8 (manufacturing and evaluation of external preparations for skin)
The ingredients shown in Table 1 were blended and mixed uniformly using a homogenizer to prepare a skin external preparation having the composition shown in Table 1. The obtained external preparation for skin was evaluated by the above method. The results are shown in Table 1. The blending amount shown in Table 1 is the amount of the active ingredient (mass%) of each component.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 表1の配合成分は下記である。
*1:製造例1で得られた板状酸化チタン1
*2:製造例2で得られた板状酸化チタン2
*3:製造例3で得られた板状酸化チタン3
*4:チタン工業(株)製「ST-750EC」、球状酸化チタン、平均粒径1000nm、アスペクト比1.0
*5:BASF社製「ユビナールMC80」、パラメトキシケイ皮酸2-エチルヘキシル
*6:花王(株)製「エキセパール IPP」、パルミチン酸イソプロピル
*7:モメンティブ・パフォーマンス・マテリアルズ社製「TSF405」、デカメチルシクロペンタシロキサン
The ingredients in Table 1 are as follows.
* 1: Plate-shaped titanium oxide 1 obtained in Production Example 1
* 2: Plate-shaped titanium oxide 2 obtained in Production Example 2
* 3: Plate-shaped titanium oxide 3 obtained in Production Example 3
* 4: "ST-750EC" manufactured by Titan Kogyo Co., Ltd., spherical titanium oxide, average particle size 1000 nm, aspect ratio 1.0
* 5: BASF's "Ubinal MC80", 2-ethylhexyl paramethoxycinnamate * 6: Kao Corporation's "Exepearl IPP", isopropyl palmitate * 7: Momentive Performance Materials'"TSF405", Decamethylcyclopentasiloxane
 表1より、実施例1~12の皮膚外用剤は赤外線防御効果と、皮膚に塗布した際の自然な色合いとを両立することができる。中でも、成分(a)~(c)の配合割合が前記条件1を満たす実施例1、3、4、6、8及び9は総合評価がA以上であってより好ましく、前記条件2を満たす実施例4及び6は総合評価がA+であって更に好ましい。
 これに対し、比較例1~8の皮膚外用剤では、赤外線防御効果、又は皮膚に塗布した際の自然な色合いの少なくとも一方において充分な効果が得られなかった。
From Table 1, the external preparations for skin of Examples 1 to 12 can have both an infrared ray protective effect and a natural color when applied to the skin. Among them, Examples 1, 3, 4, 6, 8 and 9 in which the blending ratios of the components (a) to (c) satisfy the above condition 1 are more preferable because the overall evaluation is A or more, and the implementation satisfying the above condition 2. Examples 4 and 6 have a comprehensive evaluation of A +, which is more preferable.
On the other hand, the external preparations for skin of Comparative Examples 1 to 8 did not have a sufficient effect in at least one of the infrared protective effect and the natural color when applied to the skin.
 なお図1の三相図に示すA+、A、B、C、D及びD-の表記は、実施例1~12及び比較例1~8の皮膚外用剤に対応する成分(a)~(c)の組成点において、前記総合評価を示したものである。 The notation of A +, A, B, C, D and D- shown in the three-phase diagram of FIG. 1 indicates the components (a) to (c) corresponding to the external preparations for skin of Examples 1 to 12 and Comparative Examples 1 to 8. ), The comprehensive evaluation is shown.
 本発明の皮膚外用剤は、赤外線防御効果に優れ、且つ、皮膚に塗布した際に赤味や青味が認められにくく、皮膚の色になじむ自然な色合いが得られるものであり、例えば皮膚化粧料として有用である。 The external preparation for skin of the present invention has an excellent infrared protective effect, and when applied to the skin, redness and blueness are less likely to be recognized, and a natural color that blends in with the skin color can be obtained. For example, skin makeup. It is useful as a fee.
1  成分(a)~(c)の合計配合量100質量%に対する成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、且つ成分(c)の配合量が5質量%以上70質量%以下となる組成領域
2  条件1を満たす組成領域
3  条件2を満たす組成領域
1 The blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass or less with respect to the total blending amount of 100% by mass of the components (a) to (c). Composition region 2 in which the blending amount of the component (c) is 5% by mass or more and 70% by mass or less Composition region satisfying condition 1 Composition region satisfying condition 2

Claims (9)

  1.  下記成分(a)~(c):
    (a)厚さ100nm以上120nm以下の板状金属酸化物、
    (b)厚さ125nm以上145nm以下の板状金属酸化物、及び
    (c)厚さ180nm以上200nm以下の板状金属酸化物、
    を配合してなり、
     該成分(a)~(c)の合計配合量100質量%に対し、成分(a)の配合量が5質量%以上70質量%以下、成分(b)の配合量が15質量%以上75質量%以下、成分(c)の配合量が5質量%以上70質量%以下である、皮膚外用剤。
    The following components (a) to (c):
    (A) Plate-like metal oxide with a thickness of 100 nm or more and 120 nm or less,
    (B) Plate-shaped metal oxides with a thickness of 125 nm or more and 145 nm or less, and (c) Plate-shaped metal oxides with a thickness of 180 nm or more and 200 nm or less.
    It is made by blending
    The blending amount of the component (a) is 5% by mass or more and 70% by mass or less, and the blending amount of the component (b) is 15% by mass or more and 75% by mass with respect to the total blending amount of the components (a) to (c) of 100% by mass. % Or less, and the blending amount of the component (c) is 5% by mass or more and 70% by mass or less, which is an external preparation for skin.
  2.  前記板状金属酸化物が板状酸化チタンである、請求項1に記載の皮膚外用剤。 The skin external preparation according to claim 1, wherein the plate-shaped metal oxide is plate-shaped titanium oxide.
  3.  前記成分(a)~(c)の平均粒径が1μm以上20μm以下である、請求項1又は2に記載の皮膚外用剤。 The skin external preparation according to claim 1 or 2, wherein the average particle diameters of the components (a) to (c) are 1 μm or more and 20 μm or less.
  4.  前記皮膚外用剤における成分(a)~(c)の合計配合量が1質量%以上35質量%以下である、請求項1~3のいずれか1項に記載の皮膚外用剤。 The skin external preparation according to any one of claims 1 to 3, wherein the total amount of the components (a) to (c) in the skin external preparation is 1% by mass or more and 35% by mass or less.
  5.  さらに成分(d)として感触向上剤を含有する、請求項1~4のいずれか1項に記載の皮膚外用剤。 The skin external preparation according to any one of claims 1 to 4, further containing a feel-improving agent as the component (d).
  6.  さらに成分(e)として紫外線吸収剤を含有する、請求項1~5のいずれか1項に記載の皮膚外用剤。 The external preparation for skin according to any one of claims 1 to 5, further containing an ultraviolet absorber as a component (e).
  7.  さらに成分(f)として油剤を含有する、請求項1~6のいずれか1項に記載の皮膚外用剤。 The skin external preparation according to any one of claims 1 to 6, further containing an oil agent as the component (f).
  8.  皮膚化粧料である、請求項1~7のいずれか1項に記載の皮膚外用剤。 The external preparation for skin according to any one of claims 1 to 7, which is a skin cosmetic.
  9.  請求項1~8のいずれか1項に記載の皮膚外用剤を皮膚に塗布する皮膚の赤外線防御方法。 A method for protecting the skin from infrared rays by applying the external preparation for skin according to any one of claims 1 to 8 to the skin.
PCT/JP2020/042695 2019-11-20 2020-11-17 External preparation for skin WO2021100676A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202080079384.4A CN114727920A (en) 2019-11-20 2020-11-17 External preparation for skin
KR1020227015676A KR20220080162A (en) 2019-11-20 2020-11-17 skin external preparations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019209728 2019-11-20
JP2019-209728 2019-11-20

Publications (1)

Publication Number Publication Date
WO2021100676A1 true WO2021100676A1 (en) 2021-05-27

Family

ID=75964161

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/042695 WO2021100676A1 (en) 2019-11-20 2020-11-17 External preparation for skin

Country Status (5)

Country Link
JP (1) JP2021080251A (en)
KR (1) KR20220080162A (en)
CN (1) CN114727920A (en)
TW (1) TW202128123A (en)
WO (1) WO2021100676A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016204267A (en) * 2015-04-15 2016-12-08 花王株式会社 Powder cosmetic
JP2017095361A (en) * 2015-11-18 2017-06-01 花王株式会社 Near-infrared ray shielding cosmetic composition
JP2017122075A (en) * 2016-01-08 2017-07-13 花王株式会社 Oil-in-water skin cosmetic
JP2017155006A (en) * 2016-03-02 2017-09-07 株式会社コスモビューティー Composite particle, cosmetic composition, and method for producing composite particle
JP2017171655A (en) * 2016-03-17 2017-09-28 大塚製薬株式会社 Skin external composition for blocking near infrared radiation
JP2019006712A (en) * 2017-06-26 2019-01-17 御木本製薬株式会社 Water-in-oil type emulsified composition
JP2019131499A (en) * 2018-01-30 2019-08-08 株式会社コーセー Skin external preparations or cosmetics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3874412B2 (en) * 2002-09-30 2007-01-31 株式会社資生堂 Topical skin preparation
JP4874577B2 (en) * 2005-06-10 2012-02-15 株式会社クラレ Topical skin preparation
KR20100055433A (en) * 2007-07-30 2010-05-26 요헤이 타나카 Protective agent against damage of biological tissue caused by near-infrared ray, and product comprising the same
JP5839984B2 (en) * 2011-12-23 2016-01-06 日揮触媒化成株式会社 Method for producing metal oxide particles
JP6003287B2 (en) * 2012-06-26 2016-10-05 日油株式会社 O / W type UV cosmetic skin protection
JP5878447B2 (en) * 2012-09-12 2016-03-08 富士フイルム株式会社 Base makeup cosmetics
JP2015086157A (en) * 2013-10-30 2015-05-07 ポーラ化成工業株式会社 External preparation for skin
JP6580907B2 (en) * 2014-11-20 2019-09-25 花王株式会社 Skin cosmetics
JP2016204368A (en) * 2015-04-14 2016-12-08 株式会社Applause Composition comprising cerium oxide fine particle
JP2017036221A (en) * 2015-08-06 2017-02-16 三菱瓦斯化学株式会社 Particles for cosmetic and method for producing the same, and cosmetic composition using particles for cosmetic
JP2017141179A (en) * 2016-02-09 2017-08-17 株式会社クレハ Skin external preparation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016204267A (en) * 2015-04-15 2016-12-08 花王株式会社 Powder cosmetic
JP2017095361A (en) * 2015-11-18 2017-06-01 花王株式会社 Near-infrared ray shielding cosmetic composition
JP2017122075A (en) * 2016-01-08 2017-07-13 花王株式会社 Oil-in-water skin cosmetic
JP2017155006A (en) * 2016-03-02 2017-09-07 株式会社コスモビューティー Composite particle, cosmetic composition, and method for producing composite particle
JP2017171655A (en) * 2016-03-17 2017-09-28 大塚製薬株式会社 Skin external composition for blocking near infrared radiation
JP2019006712A (en) * 2017-06-26 2019-01-17 御木本製薬株式会社 Water-in-oil type emulsified composition
JP2019131499A (en) * 2018-01-30 2019-08-08 株式会社コーセー Skin external preparations or cosmetics

Also Published As

Publication number Publication date
JP2021080251A (en) 2021-05-27
CN114727920A (en) 2022-07-08
KR20220080162A (en) 2022-06-14
TW202128123A (en) 2021-08-01

Similar Documents

Publication Publication Date Title
KR101563853B1 (en) Sunscreen cosmetic
KR101860977B1 (en) Oil-in-water-type emulsion cosmetic
JP4560122B2 (en) Titanium oxide dispersion and cosmetics containing the same
JP2017122075A (en) Oil-in-water skin cosmetic
JP7295797B2 (en) Water-in-oil emulsified cosmetic
JP2017095361A (en) Near-infrared ray shielding cosmetic composition
JP2017137300A (en) Oil-in-water type emulsion cosmetic
JP2007084475A (en) Low viscosity oil-in-water type emulsion cosmetic
WO2021100676A1 (en) External preparation for skin
JP6865522B2 (en) Underwater oil type UV protection cosmetics
WO2022239842A1 (en) Skin external agent
CN113195060B (en) External preparation
TWI828835B (en) Skin external preparations
JP2020105175A (en) External preparation for skin
JP2020105177A (en) External preparation for skin
JP2020105176A (en) External preparation for skin
WO2020138431A1 (en) External preparation
JP2020128344A (en) Oil-in-water emulsion cosmetic
WO2021193854A1 (en) Oil-in-water-type emulsified cosmetic material
JP2022051592A (en) Water-in-oil type emulsion cosmetic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20889053

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20227015676

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20889053

Country of ref document: EP

Kind code of ref document: A1